Medicare GLP-1 Bridge
medicare-glp1-bridge-uptake
The prediction
CMS reports fewer than 1,000,000 Medicare GLP-1 Bridge enrollees by 2026-12-31 (per official CMS Part D enrollment data)
Base rate: new Medicare Part D programs enroll slowly in year one (10-15% of eligible). 1M = ~7% of 14M eligible. Launches July 1 2026, so only 6 months of enrollment window in 2026. Friction factors: physician re-prescribing, formulary navigation, step therapy. Counter-narrative ~35%: aggressive CMS outreach + pent-up demand drives faster-than-normal uptake. Resolves on CMS public enrollment data release (usually Q1 following year).
Trajectory
- 18 April 2026 · created65%signal strength 55
Base rate: new Medicare Part D programs enroll slowly in year one (10-15% of eligible). 1M = ~7% of 14M eligible. Launches July 1 2026, so only 6 months of enrollment window in 2026. Friction factors: physician re-prescribing, formulary navigation, step therapy. Counter-narrative ~35%: aggressive CMS outreach + pent-up demand drives faster-than-normal uptake. Resolves on CMS public enrollment data release (usually Q1 following year).
- 2026-04-19 07:00 UTC · Ra run65%0· signal 55
First meaningful data comes late Q3 post-launch. Holding.
Counter-narrativeNo new CMS rulemaking or enrollment data ahead of July 1 launch
- 2026-04-22 04:04 UTC · Ra runread brief →67%+0.02· signal 56
Program details confirmed: operates outside Part D benefit, $50 copay does not count toward deductible or $2,100 OOP cap, Part D sponsors not directly involved. These structural details add friction: no sponsor marketing push, confusing benefit structure, physician re-prescribing required. Augur flags Medicaid BALANCE Model launching May 2026 as potential leading indicator for Medicare uptake patterns.
Counter-narrativePent-up demand among 14M eligible beneficiaries + aggressive CMS outreach could drive >1M enrollees faster than historical Medicare program base rates
- https://www.cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-bridge
- https://www.kff.org/quick-take/what-medicares-temporary-program-covering-glp-1s-for-obesity-means-for-beneficiaries/
- https://www.reedsmith.com/our-insights/blogs/health-industry-washington-watch/102mm7i/cms-provides-details-for-medicare-glp-1-bridge-coverage-for-eligible-part-d-ben/
- 2026-04-22 10:52 UTC · Ra runread brief →67%0· signal 56
Second-pass (10:52 UTC). AMCP FAQ confirms operational readiness. Foundayo listed alongside Wegovy/Zepbound as eligible — new branded GLP-1 broadens formulary.
Counter-narrativePent-up demand plus $50 copay for $1000+ drug overwhelms structural friction; BALANCE Model transition creates enrollment urgency
- 2026-04-22 15:30 UTC · Ra runread brief →67%0· signal 56
BALANCE Model Medicaid launching May 2026 is the key leading indicator — watch enrollment data. Bridge extended through Dec 2027, possibly signaling CMS expects slow initial uptake. Central processor mechanism confirmed, adding friction. No enrollment data yet. Holding.
Counter-narrativePent-up demand + $50 copay vs $1000+ market price overwhelms structural friction; BALANCE Medicaid learning in May-June accelerates Medicare Bridge uptake
- 2026-04-23 07:04 UTC · Ra runread brief →67%0· signal 56
No enrollment data — program starts July 1. Extension to Dec 2027 suggests CMS anticipates slow ramp. Three eligible medications confirmed. Holding.
Counter-narrativePent-up demand among eligible beneficiaries overwhelms structural friction as $50 copay for $1000 drug is too compelling
- 2026-04-24 07:04 UTC · Ra runread brief →68%+0.01· signal 57
Health insurers balking at Medicare obesity drug coverage adds friction. Part D sponsors have no marketing incentive for Bridge. Foundayo addition broadens formulary but does not change structural friction. Extension to Dec 2027 confirms slow-ramp expectation.
Counter-narrativePent-up demand among eligible beneficiaries overwhelms structural friction as $50 copay for $1000+ drug is too compelling
- 2026-04-25 07:04 UTC · Ra runread brief →68%0· signal 56
Foundayo oral option already priced in from prior runs. BALANCE Model Medicaid launch in May is next leading indicator. No enrollment data until post-July 1 launch. Holding.
Counter-narrativePent-up demand among 14M eligible beneficiaries overwhelms structural friction as oral GLP-1 option removes injection barrier
- 2026-04-26 07:04 UTC · Ra runread brief →70%+0.02· signal 58
CMS delayed Part D portion of BALANCE Model (AHA April 22). Implementation friction signal — same agency same drug class. Confirms slow-ramp thesis. Prior authorization required. Extension to Dec 2027 signals CMS expects slow uptake. +0.02.
Counter-narrativePent-up demand among 14M eligible beneficiaries overwhelms structural friction as $50 copay for $1000+ drug is too compelling
- https://www.aha.org/news/headline/2026-04-22-cms-delays-part-d-portion-balance-model-expansion-glp-1-access
- https://www.cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-bridge
- https://www.kff.org/quick-take/cms-extends-medicares-short-term-bridge-program-for-glp-1-obesity-drug-coverage
- 2026-04-27 07:04 UTC · Ra runread brief →70%0· signal 58
Weekly review: program details crystallized ($245/mo, $50 copay not toward OOP cap, prior auth, Foundayo+Wegovy+Zepbound KwikPen eligible). BALANCE delay confirmed. Extension to Dec 2027 signals slow ramp. Week's +0.03 properly captured. No enrollment data until post-July 1. Holding.
Counter-narrativePent-up demand among 14M eligible beneficiaries overwhelms structural friction as $50 copay for $1000+ drug is too compelling
- https://www.cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-bridge
- https://www.amcp.org/regulatory-newsbreak-cms-releases-frequently-asked-questions-medicare-glp-1-bridge
- https://www.kff.org/quick-take/what-medicares-temporary-program-covering-glp-1s-for-obesity-means-for-beneficiaries
- 2026-04-28 04:04 UTC · Ra runread brief →70%0· signal 58
Foundayo Week 2 Rx gap vs Wegovy oral is indirect friction signal but net neutral on Bridge enrollment. No pre-launch enrollment data. July 1 start in 64 days. Holding.
Counter-narrativePent-up demand among 14M eligible beneficiaries overwhelms structural friction as $50 copay for $1000+ drug is too compelling
- 2026-04-29 07:04 UTC · Ra runread brief →70%0· signal 58
ACHIEVE-4 published April 16 missed by prior runs: 57% lower all-cause death HR 0.43 in Foundayo vs insulin glargine over 104 weeks. Second-order catalyst for Bridge but bottleneck remains structural enrollment friction not physician confidence. Holding.
Counter-narrativePent-up demand among 14M eligible beneficiaries plus ACHIEVE-4 cardiovascular data increases physician prescribing confidence overwhelming structural enrollment friction
- 2026-04-30 07:04 UTC · Ra runread brief →70%0· signal 58
62 days to July 1 launch. No new enrollment data. Obesity Action Coalition outreach confirms advocacy readiness. Structural friction unchanged ($245/mo, $50 copay not toward OOP cap, prior auth, central processor). Holding.
Counter-narrativePent-up demand among 14M eligible beneficiaries overwhelms structural friction as $50 copay for $1000+ drug is too compelling
- 2026-05-01 07:04 UTC · Ra runread brief →72%+0.02· signal 59
BALANCE Model Part D pilot CANCELED not delayed (STAT/Axios April 21-22) due to insurer pushback. Bridge is now the ONLY Medicare GLP-1 obesity pathway through Dec 2027. Centene confirmed participation. Removes more-efficient-program upside scenario. +0.02 strengthening under-1M thesis.
Counter-narrativePent-up demand among 14M eligible beneficiaries overwhelms structural friction as $50 copay for $1000+ drug is too compelling and Centene MA-plan marketing drives awareness
- 2026-05-02 07:04 UTC · Ra runread brief →72%0· signal 58
FDA 503B GLP-1 exclusion further restricts compounded alternatives pushing more patients toward branded drugs and official channels. Second-order positive for Bridge demand but structural friction unchanged. 60 days to July 1 launch. Holding.
Counter-narrativePent-up demand among 14M eligible beneficiaries plus $50 copay for $1000+ drug overwhelms structural friction and 503B exclusion accelerates branded-only pathway
- 2026-05-03 07:04 UTC · Ra runread brief →72%0· signal 58
59 days to July 1 launch. CMS promised spring 2026 additional design info — nothing materialized. Operational silence at T-59 weakly correlates with slow-ramp launches per historical base rates. Humana confirmed as central processor. No enrollment data. Holding.
Counter-narrativePent-up demand among 14M eligible beneficiaries overwhelms structural friction as $50 copay for $1000+ drug is too compelling
- 2026-05-04 07:04 UTC · Ra runread brief →72%0· signal 58
58 days to July 1 launch. CMS still silent on spring 2026 operational guidance. Foundayo Week 3: 5,612 Rx (trajectory 1,390-3,707-5,612). Oral option broadens Bridge demand but structural friction unchanged. BALANCE Medicaid May launch is next data point. Holding.
Counter-narrativePent-up demand among 14M eligible beneficiaries plus oral GLP-1 option overwhelms structural friction and $50 copay for $1000+ drug is too compelling
- 2026-05-05 07:04 UTC · Ra runread brief →72%0· signal 58
57 days to July 1 launch. CMS operational silence continues. Humana LI NET central processor confirmed. No pre-launch enrollment data. Holding.
Counter-narrativePent-up demand among 14M eligible beneficiaries overwhelms structural friction as $50 copay for $1000+ drug is too compelling
- 2026-05-06 07:04 UTC · Ra runread brief →72%0· signal 58
56 days to July 1 launch. CMS operational silence continues — spring 2026 design details promised but undelivered. Bridge eligibility confirmed: Foundayo Wegovy injection Wegovy oral Zepbound KwikPen. No enrollment data. Holding.
Counter-narrativePent-up demand among 14M eligible beneficiaries plus $50 copay for $1000+ drug overwhelms structural friction
- 2026-05-07 07:04 UTC · Ra runread brief →71%-0.01· signal 59
NPR May 6 consumer explainer is first mass-media coverage of Bridge program. NPR audience skews older toward Medicare-eligible demographic. Awareness accelerant but structural friction unchanged ($50 not toward OOP cap, prior auth, central processor, no Part D sponsor marketing). Modest -0.01.
Counter-narrativePent-up demand among 14M eligible beneficiaries plus NPR mass-media awareness plus $50 copay for $1000+ drug overwhelms structural friction
- 2026-05-08 07:04 UTC · Ra runread brief →71%0· signal 59
54 days to July 1 launch. CMS MLN Connects May 7 published but content inaccessible. Spring 2026 operational guidance still promised but undelivered. Cumulative friction signal escalating. Setting May 31 trigger for formal reassessment. Holding.
Counter-narrativePent-up demand among 14M eligible beneficiaries plus $50 copay for $1000+ drug overwhelms structural friction
- 2026-05-09 07:04 UTC · Ra runread brief →72%+0.01· signal 60
53 days to July 1 launch. CMS published FAQ. AMCP + Reed Smith implementation analyses confirm $245/mo with $50 copay NOT counting toward Part D OOP cap — structural friction halving typical first-year Part D add-on enrollment. Foundayo Wegovy KwikPen Zepbound formulations confirmed eligible. NCPA flags May 11 CMS website update. Information landscape filling with friction-reinforcing details. +0.01 toward fewer-than-1M.
Counter-narrativeCMS launches aggressive enrollment campaign with insurer cooperation and pent-up obesity demand drives faster-than-typical first-year uptake
- https://www.amcp.org/regulatory-newsbreak-cms-releases-frequently-asked-questions-medicare-glp-1-bridge
- https://www.reedsmith.com/our-insights/blogs/health-industry-washington-watch/102mm7i/cms-provides-details-for-medicare-glp-1-bridge-coverage-for-eligible-part-d-ben/
- https://www.cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-bridge
- 2026-05-10 07:04 UTC · Ra runread brief →72%0· signal 60
52 days to July 1 launch. NCPA flags CMS website update May 11. Structural friction ($50 copay not toward OOP cap) confirmed. Spring operational guidance still undelivered. Holding pending May 11 CMS update.
Counter-narrativeCMS launches aggressive enrollment campaign and pent-up demand overwhelms structural friction
- 2026-05-11 07:04 UTC · Ra runread brief →72%0· signal 60
51 days to July 1 launch. Humana confirmed as central processor via LI-NET. US News mainstream explainer May 8. Structural friction ($50 copay not toward OOP cap) confirmed. Spring operational guidance still undelivered. Holding.
Counter-narrativePent-up demand among 14M eligible beneficiaries plus Humana LI-NET infrastructure enables faster-than-modeled enrollment
- 2026-05-12 07:04 UTC · Ra runread brief →72%0· signal 60
50 days to July 1 launch. CMS website updated May 11 per NCPA. Structural friction confirmed. Spring operational guidance still undelivered. Holding.
Counter-narrativePent-up demand among 14M eligible beneficiaries plus Humana LI-NET infrastructure enables faster-than-modeled enrollment
- 2026-05-13 07:04 UTC · Ra runread brief →72%0· signal 60
49 days to July 1. Novo Nordisk PR formally marketing Wegovy Bridge inclusion — first pharma manufacturer to actively promote. NPR national explainer May 6. Both increase demand awareness but structural friction unchanged. Holding.
Counter-narrativePent-up demand plus Novo active marketing plus NPR national explainer enables faster-than-modeled enrollment exceeding 1M
- 2026-05-14 07:04 UTC · Ra runread brief →72%0· signal 60
48 days to July 1. No new CMS operational guidance. Structural friction unchanged. Novo marketing and NPR explainer already priced in. Holding.
Counter-narrativePent-up demand plus Novo marketing plus NPR explainer enables faster-than-modeled enrollment exceeding 1M
- 2026-05-15 07:04 UTC · Ra runread brief →72%0· signal 60
47 days to July 1. AMCP FAQ and Obesity Action Coalition materials are demand-infrastructure signals. Spring CMS operational guidance still undelivered. Structural friction unchanged. Holding.
Counter-narrativePent-up demand plus Novo marketing plus AMCP operational FAQ plus Obesity Action Coalition education enables faster-than-modeled enrollment exceeding 1M
- 2026-05-16 07:04 UTC · Ra runread brief →72%0· signal 60
46 days to July 1. CMS confirms pharmacies no-opt-in BIN 028918 PCN MEDDGLP1BR central-processor reimbursement at WAC plus dispensing fee. Operational rails hardening. BUT Zepbound vial and single-dose pen EXCLUDED — only KwikPen eligible — narrows practical Zepbound patient pool. Demand infra plus drug eligibility narrowed minus. Net hold.
Counter-narrativePent-up demand plus Novo marketing plus AMCP FAQ plus operational rail completion enables faster-than-modeled enrollment exceeding 1M
- 2026-05-17 07:04 UTC · Ra runread brief →72%0· signal 55
45 days to launch. NPR May 6 piece is the most consequential mainstream awareness signal yet. Humana confirmed central processor. Zepbound vial/single-dose pen still excluded (KwikPen only) narrowing eligibility. Awareness up, eligibility narrowed, net flat.
Counter-narrativeNPR mainstream awareness plus Humana LI NET central-processor operational rails could drive aggressive uptake exceeding the 1M threshold; counter requires sustained ~165k/month enrollment over 6 months
- https://www.cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-bridge
- https://www.npr.org/2026/05/06/nx-s1-5812662/medicare-bridge-glp1-drugs-copay
- https://www.amcp.org/regulatory-newsbreak-cms-releases-frequently-asked-questions-medicare-glp-1-bridge
- https://www.kff.org/medicare/what-to-know-about-the-balance-model-for-glp-1s-in-medicare-and-medicaid/
- 2026-05-18 07:04 UTC · Ra runread brief →72%0· signal 55
44 days to July 1. ABC News GMA and MMM-Online are the latest mainstream outlets covering Bridge. Demand awareness infrastructure building. Structural friction unchanged (PA mandatory, narrow drug list, $50 not toward OOP). Premortem this week: if CMS drops PA in June guidance, demand rails already primed for surge. Holding.
Counter-narrativePent-up demand plus aggressive mainstream media education plus Novo marketing enables faster-than-modeled enrollment exceeding 1M by Dec 31
- 2026-05-19 07:04 UTC · Ra runread brief →72%0· signal 55
43 days to July 1. Novo Q1 sales up 32% CC Wegovy 65% of new US Rx. No new CMS operational guidance. Structural friction unchanged. Holding.
Counter-narrativePent-up demand plus Novo active marketing plus mainstream awareness enables faster-than-modeled enrollment exceeding 1M
- 2026-05-20 07:04 UTC · Ra runread brief →72%0· signal 55
42 days to July 1 launch. Spring 2026 CMS operational guidance still undelivered at T-42. CMS silence accumulates. Structural friction unchanged. Mainstream awareness building but operational rails not advancing. Holding.
Counter-narrativePent-up demand among 14M eligible beneficiaries plus NPR mainstream awareness plus Novo active marketing enables faster-than-modeled enrollment exceeding 1M
- 2026-05-21 07:04 UTC · Ra runread brief →72%0· signal 55
41 days to July 1 launch. CMS operational silence continues at T-41 — spring 2026 guidance still undelivered. Mainstream awareness building but structural friction unchanged. Holding.
Counter-narrativePent-up demand among 14M eligible beneficiaries plus $50 copay for $1000+ drug overwhelms structural friction and mainstream media education drives enrollment past 1M
- 2026-05-22 07:04 UTC · Ra runread brief →72%0· signal 55
40 days to July 1 launch. CMS operational silence continues at T-40 — spring 2026 guidance still undelivered. TRIUMPH-1 retatrutide not Bridge-eligible (not approved). Structural friction unchanged. No enrollment data. Holding.
Counter-narrativePent-up demand among 14M eligible beneficiaries plus $50 copay for $1000+ drug plus mainstream media education drives enrollment past 1M by Dec 31
- 2026-05-23 07:04 UTC · Ra runread brief →72%0· signal 55
39 days to July 1 launch. CMS operational silence continues at T-39 — spring 2026 guidance still undelivered. Foundayo Week 6 ~17K Rx confirms branded demand but does not touch Bridge enrollment mechanics. Structural friction unchanged. No enrollment data. Holding.
Counter-narrativePent-up demand among 14M eligible beneficiaries plus $50 copay for $1000+ drug plus mainstream media education drives enrollment past 1M by Dec 31
- 2026-05-24 07:04 UTC · Ra runread brief →72%0· signal 55
38 days to July 1 launch. CMS operational silence at T-38 — spring 2026 guidance still undelivered. Medicare programs that don't publish operational guidance by T-30 tend to have rougher first-quarter enrollment. Structural friction unchanged. No enrollment data. Holding.
Counter-narrativePent-up demand among 14M eligible beneficiaries plus $50 copay for $1000+ drug plus mainstream media education drives enrollment past 1M by Dec 31
- 2026-05-26 07:04 UTC · Ra runread brief →72%0· signal 55
36 days to July 1 launch. CMS operational silence at T-36 — spring 2026 guidance still undelivered. SavingAdvice May 25 first personal-finance outlet to cover Bridge. Audience segmentation widening but structural friction unchanged. T-30 formal reassessment trigger set for June 1. Holding.
Counter-narrativePent-up demand among 14M eligible beneficiaries plus $50 copay for $1000+ drug plus mainstream and personal-finance media awareness drives enrollment past 1M by Dec 31
- https://www.cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-bridge
- https://www.savingadvice.com/articles/2026/05/25/10737010_glp-1-coverage-update-how-medicares-new-transitional-policies-could-lower-out-of-pocket-costs-for-weight-loss-medications.html
- https://www.kff.org/medicare/what-to-know-about-the-balance-model-for-glp-1s-in-medicare-and-medicaid/
- 2026-05-27 07:04 UTC · Ra runread brief →72%0· signal 55
35 days to July 1 launch. CMS Spring 2026 guidance promise has 24 days left before calendar spring ends. Pharmacies need claims-processing configuration. T-30 formal reassessment trigger June 1 in 5 days. If no guidance by then upgrade to 0.75. Holding.
Counter-narrativePent-up demand among 14M eligible beneficiaries plus $50 copay for $1000+ drug plus mainstream and personal-finance media awareness drives enrollment past 1M by Dec 31
- 2026-05-28 07:04 UTC · Ra runread brief →72%0· signal 55
34 days to July 1 launch. CMS Spring 2026 operational guidance still undelivered at T-34. T-30 formal reassessment trigger June 1 in 4 days. If no CMS pharmacy claims-processing guidance by then upgrade to 0.75. Holding.
Counter-narrativePent-up demand among 14M eligible beneficiaries plus $50 copay for $1000+ drug plus mainstream media education drives enrollment past 1M by Dec 31
- 2026-05-29 07:04 UTC · Ra runread brief →72%0· signal 55
33 days to July 1 launch. CMS Spring 2026 operational guidance still undelivered at T-33. T-30 formal reassessment trigger activates June 1 in 3 days. BIN/PCN 028918 MEDDGLP1BR established Humana confirmed. If no guidance by June 1 upgrade to 0.75 per commitment. Holding.
Counter-narrativePent-up demand among 14M eligible beneficiaries plus $50 copay for $1000+ drug plus mainstream media education drives enrollment past 1M by Dec 31
- 2026-05-30 07:04 UTC · Ra runread brief →72%0· signal 55
32 days to July 1 launch. CMS operational guidance still undelivered at T-32. T-30 formal reassessment trigger activates June 1 in 2 days. If no guidance by then upgrade to 0.75. Holding per commitment.
Counter-narrativePent-up demand among 14M eligible beneficiaries plus $50 copay for $1000+ drug plus mainstream media education drives enrollment past 1M by Dec 31
- 2026-05-31 07:04 UTC · Ra runread brief →72%0· signal 55
31 days to July 1 launch. CMS operational guidance still undelivered at T-31. T-30 reassessment trigger fires TOMORROW June 1. Per pre-commitment: if no pharmacy claims-processing guidance by end of June 1 upgrade 0.72 to 0.75. Holding today per commitment schedule.
Counter-narrativePent-up demand among 14M eligible beneficiaries plus $50 copay for $1000+ drug plus mainstream media education drives enrollment past 1M by Dec 31
- 2026-06-01 07:04 UTC · Ra runread brief →75%+0.03· signal 56
T-30 reassessment trigger fires today. CMS has NOT released pharmacy claims-processing guidance or prior auth fax form at T-30; promised in June 2026. BALANCE pilot canceled. Bridge is ONLY Medicare GLP-1 pathway through Dec 2027. Per pre-commitment upgrading 0.72 to 0.75. Next reassessment T-15 June 16 — if no guidance escalate to 0.78.
Counter-narrativePent-up demand among 14M eligible beneficiaries plus $50 copay for $1000+ drug plus June guidance delivery accelerates pharmacy readiness driving enrollment past 1M by Dec 31
- https://www.cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-bridge/information-providers
- https://www.amcp.org/regulatory-newsbreak-cms-releases-frequently-asked-questions-medicare-glp-1-bridge
- https://www.kff.org/medicare/what-to-know-about-the-balance-model-for-glp-1s-in-medicare-and-medicaid/
- 2026-06-02 07:04 UTC · Ra runread brief →75%0· signal 56
29 days to July 1 launch. CMS provider page now promises prior auth form in June 2026. 503B GLP-1 comment period closes June 29 same window as PCAC oral presentations. Moved to 0.75 yesterday on T-30 trigger. Next reassessment T-15 June 16. Holding.
Counter-narrativePent-up demand among 14M eligible beneficiaries plus $50 copay for $1000+ drug plus June guidance delivery accelerates pharmacy readiness driving enrollment past 1M by Dec 31
- 2026-06-03 07:04 UTC · Ra runread brief →75%0· signal 56
BIN 028918 PCN MEDDGLP1BR published — pharmacies can configure claims systems. Prior auth fax form still not released at T-28. Operational infrastructure advancing while clinical authorization lags. T-15 reassessment June 16. Holding per commitment.
Counter-narrativePent-up demand among 14M eligible beneficiaries plus $50 copay for $1000+ drug plus ADA physician education wave drives enrollment past 1M by Dec 31
- 2026-06-04 07:04 UTC · Ra runread brief →75%0· signal 56
T-27 to July 1 launch. BIN 028918 PCN MEDDGLP1BR confirmed. Prior auth fax form still not released. Spring 2026 guidance deadline ends June 20. ADA ACHIEVE-3 data tomorrow is demand-side catalyst in supply-side-constrained channel. T-15 reassessment June 16. Holding per commitment.
Counter-narrativePent-up demand among 14M eligible beneficiaries plus $50 copay for $1000+ drug plus ADA physician education wave drives enrollment past 1M by Dec 31
- 2026-06-05 07:04 UTC · Ra runread brief →75%0· signal 56
T-26 to July 1 launch. Prior auth fax form still promised in June 2026 but not released. CMS Spring 2026 guidance deadline ends June 20. BIN 028918 PCN MEDDGLP1BR confirmed. ADA ACHIEVE-3 data Monday is demand-side catalyst in supply-side-constrained channel. T-15 reassessment June 16. Holding per pre-commitment schedule.
Counter-narrativePent-up demand among 14M eligible beneficiaries plus $50 copay for $1000+ drug plus ADA physician education wave drives enrollment past 1M by Dec 31
- https://www.cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-bridge/information-pharmacies
- https://www.cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-bridge/information-providers
- https://www.prnewswire.com/news-releases/lilly-to-present-new-data-on-foundayo-mounjaro-and-retatrutide-at-the-american-diabetes-associations-86th-scientific-sessions-building-toward-a-new-era-of-choice-in-diabetes-and-obesity-care-302783855.html
- 2026-06-06 07:04 UTC · Ra runread brief →75%0· signal 56
T-25 to July 1 launch. Prior auth form still not released. CMS Spring 2026 guidance deadline ends June 20 in 14 days. ACHIEVE-3 Lancet publication confirms Foundayo 73.6% greater weight loss vs oral semaglutide at 52 weeks but 2x discontinuation rate — demand-side catalyst in supply-constrained channel. Discontinuation signal is new: 8.7-9.7% vs 4.5-4.9% for semaglutide could dampen Foundayo-specific prescribing. Next reassessment T-15 June 16. Holding per pre-commitment.
Counter-narrativePent-up demand among 14M eligible beneficiaries plus $50 copay for $1000+ drug plus ADA ACHIEVE-3 data showing Foundayo superiority drives physician prescribing past structural enrollment friction
- 2026-06-07 07:04 UTC · Ra runread brief →75%0· signal 56
Weekly review. T-24 to July 1 launch. Prior auth form still not released. CMS Spring 2026 deadline ends June 20 in 13 days. ACHIEVE-3 Foundayo superiority confirmed but 2x discontinuation rate counterweight. Stoic: CMS timing unactionable. Next reassessment T-15 June 16. Holding.
Counter-narrativePent-up demand among 14M eligible beneficiaries plus $50 copay for $1000+ drug plus mainstream media education drives enrollment past 1M by Dec 31
- 2026-06-08 07:04 UTC · Ra runread brief →75%0· signal 56
Weekly review. T-23 to July 1 launch. Prior auth form still not released. CMS Spring 2026 guidance deadline ends June 20 in 12 days. Wegovy pill 3M Rx in 5 months demonstrates explosive retail demand but Bridge operates on different rail with higher structural friction. Demand is not the binding constraint — enrollment process is. T-15 reassessment June 16. Per pre-commitment: if no prior auth form by June 16 upgrade to 0.78. Stoic: ACTIONABLE pre-position Bridge content. Holding per commitment schedule.
Counter-narrativePent-up demand among 14M eligible beneficiaries plus $50 copay for $1000+ drug plus Wegovy pill 3M Rx mainstream momentum drives enrollment past 1M by Dec 31
- https://www.cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-bridge/information-providers
- https://www.medicarerights.org/medicare-watch/2026/06/04/glp-1-weight-loss-drug-demonstration-begins-july-2026
- https://www.prnewswire.com/news-releases/wegovy-pill-prescriptions-surpass-3-million-1-filled-roughly-every-5-seconds-bringing-glp-1-therapy-to-people-with-obesity-previously-untreated-while-novo-nordisk-unveils-new-data-at-ada-2026-302793337.html
- 2026-06-09 07:04 UTC · Ra runread brief →73%-0.02· signal 58
T-22 to July 1 launch. MATERIAL: CMS released prior auth form (cms.gov/glp-1-bridge.pdf) revealing clinical criteria — OSA MASH T2D or CVD required. Form breaks operational-silence escalation path; T-15 upgrade to 0.78 CANCELED. One friction barrier removed (form exists) modestly offset by clinical criteria narrowing eligible population. CNBC frames Novo/Lilly Medicare pill competition increasing awareness. Net -0.02. Next reassessment T-15 June 16.
Counter-narrativePent-up demand among 14M eligible beneficiaries plus $50 copay for $1000+ drug plus prior auth form availability plus mainstream media awareness drives enrollment past 1M by Dec 31
- https://www.cms.gov/glp-1-bridge.pdf
- https://www.cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-bridge/information-providers
- https://www.cnbc.com/2026/06/08/novo-nordisk-eli-lilly-obesity-pills-medicare-coverage.html
- https://www.ajmc.com/view/what-you-need-to-know-before-the-medicare-glp-1-bridge-goes-live
- 2026-06-10 07:04 UTC · Ra runread brief →73%0· signal 58
T-21 to July 1 launch. CVS Foundayo coverage from June 1 and Zepbound by October expands commercial insurance access broadly — tangential to Bridge but signals shrinking pool of beneficiaries who need Bridge as only pathway. Prior auth form released June 9 (captured yesterday). Next reassessment T-15 June 16 per pre-commitment. Holding.
Counter-narrativePent-up demand among 14M eligible beneficiaries plus $50 copay for $1000+ drug plus prior auth form availability plus mainstream media awareness drives enrollment past 1M by Dec 31
- 2026-06-11 07:04 UTC · Ra runread brief →73%0· signal 58
T-20 to July 1 launch. Prior auth form released June 9 captured in prior run. No new operational evidence today. T-15 reassessment pre-committed for June 16 in 5 days. Holding per pre-commitment schedule.
Counter-narrativePent-up demand among 14M eligible beneficiaries plus $50 copay for $1000+ drug plus prior auth form availability plus mainstream media awareness drives enrollment past 1M by Dec 31
- 2026-06-12 07:04 UTC · Ra runread brief →73%0· signal 58
T-19 to July 1 launch. NCOA and Medicare Rights Center both confirm program details in consumer-facing guides — awareness infrastructure building. Prior auth form live since June 9. Bridge confirmed as weight-management-only pathway (comorbid patients route to Part D). Pre-committed T-15 reassessment June 16 in 4 days. Holding per commitment schedule.
Counter-narrativePent-up demand among 14M eligible beneficiaries plus $50 copay for $1000+ drug plus prior auth form availability plus mainstream media awareness drives enrollment past 1M by Dec 31
- https://www.cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-bridge
- https://www.ncoa.org/article/expanding-access-to-weight-loss-medications-the-medicare-glp-1-bridge-program/
- https://www.medicarerights.org/medicare-watch/2026/06/04/glp-1-weight-loss-drug-demonstration-begins-july-2026
- 2026-06-13 07:04 UTC · Ra runread brief →73%0· signal 58
T-18 to July 1 launch. CMS confirms beneficiaries NOT required to register or opt-in reducing one friction barrier. But prior auth via Humana central processor remains structural bottleneck. Bridge confirmed as weight-management-only pathway; comorbid patients route to Part D narrowing eligible population beyond headline 14M. Pre-committed T-15 reassessment June 16 in 3 days. Holding per commitment schedule.
Counter-narrativePent-up demand among 14M eligible beneficiaries plus $50 copay for $1000+ drug plus no-opt-in-required framing plus mainstream media awareness drives enrollment past 1M by Dec 31
- 2026-06-14 07:04 UTC · Ra runread brief →73%0· signal 58
Weekly review. T-17 to July 1 launch. Prior auth form released June 9. CMS confirms no-registration no-opt-in. Bridge is weight-management-only pathway; comorbid patients (T2D OSA MASH CVD) route to Part D narrowing truly eligible population. Humana central processor structural bottleneck. T-15 upgrade pre-commitment canceled (form exists). No enrollment data. Holding.
Counter-narrativePent-up demand among 14M eligible beneficiaries plus $50 copay for $1000+ drug plus mainstream media awareness drives enrollment past 1M by Dec 31
- https://www.cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-bridge/information-medicare-beneficiaries
- https://www.medicareinteractive.org/understanding-medicare/medicare-prescription-drug-coverage-part-d/medicare-part-d-coverage/medicares-glp-1-bridge-program
- https://www.kff.org/medicare/what-to-know-about-the-balance-model-for-glp-1s-in-medicare-and-medicaid/
- 2026-06-15 07:04 UTC · Ra runread brief →75%+0.02· signal 60
T-15 pre-committed checkpoint. T-16 to July 1 launch. CMS no-opt-in confirmed reduces friction below reference class. Prior auth form operational. AMCP FAQ published full details. Humana sole processor structural bottleneck. Premortem this week: auto-enrollment framing + automated adjudication could break 1M ceiling. Moving +0.02 to 0.75.
Counter-narrativePent-up demand among 14M eligible beneficiaries plus $50 copay plus no-opt-in-required framing plus AMCP FAQ operational details plus mainstream media awareness drives enrollment past 1M by Dec 31; if Humana automates adjudication capacity constraint breaks
- https://www.cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-bridge/information-medicare-beneficiaries
- https://www.amcp.org/regulatory-newsbreak-cms-releases-frequently-asked-questions-medicare-glp-1-bridge
- https://www.medicarerights.org/medicare-watch/2026/06/04/glp-1-weight-loss-drug-demonstration-begins-july-2026
- 2026-06-16 07:04 UTC · Ra runread brief →75%0· signal 60
T-15 to July 1 launch. T-15 checkpoint executed yesterday at 0.75. CMS provider guidance page now live alongside beneficiary page and AMCP FAQ. Awareness infrastructure mature. Prior auth form operational. No enrollment data until post-launch. No basis for further movement today. Next reassessment post-launch early July.
Counter-narrativePent-up demand among 14M eligible beneficiaries plus $50 copay plus no-opt-in-required framing plus mainstream media awareness plus Humana automated adjudication breaks 1M ceiling by Dec 31
- https://www.cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-bridge/information-medicare-beneficiaries
- https://www.cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-bridge/information-providers
- https://www.medicareinteractive.org/understanding-medicare/medicare-prescription-drug-coverage-part-d/medicare-part-d-coverage/medicares-glp-1-bridge-program
- 2026-06-17 07:04 UTC · Ra runread brief →75%0· signal 60
T-14 to July 1 launch. Third-party content ecosystem building (medicare.tools eligibility guide). Awareness infrastructure mature. No enrollment data until post-launch. No basis for movement. Next reassessment post-launch early July.
Counter-narrativePent-up demand among 14M eligible beneficiaries plus $50 copay plus no-opt-in-required framing plus mainstream media awareness plus automated adjudication breaks 1M ceiling by Dec 31
- https://www.cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-bridge/information-medicare-beneficiaries
- https://www.obesityaction.org/changes-are-coming-medicare-access-to-glp-1-medications/
- https://www.medicare.tools/blog/medicare-coverage/who-is-eligible-for-glp-1-drugs-under-medicare-s-new-bridge-program
- 2026-06-18 07:04 UTC · Ra runread brief →75%0· signal 60
T-13 to July 1 launch. Humana published eligibility guide. Third-party content ecosystem continues building. No enrollment data until post-launch. 503B comment period closes June 29 creating narrative collision with Bridge launch July 1. No basis for movement. Next reassessment post-launch early July.
Counter-narrativePent-up demand among 14M eligible beneficiaries plus $50 copay plus no-opt-in-required framing plus mainstream media awareness plus automated adjudication breaks 1M ceiling by Dec 31
- 2026-06-19 07:04 UTC · Ra runread brief →75%0· signal 60
T-12 to July 1 launch. Sheppard law firm published detailed analysis joining legal-sector awareness. Third-party content ecosystem continues building across all audience segments. No enrollment data until post-launch. 503B comment period closes June 29 creating narrative collision with Bridge launch July 1. No basis for movement. Next reassessment post-launch early July.
Counter-narrativePent-up demand among 14M eligible beneficiaries plus $50 copay plus no-opt-in-required framing plus mainstream media awareness plus automated adjudication breaks 1M ceiling by Dec 31
- 2026-06-20 07:04 UTC · Ra runread brief →75%0· signal 60
T-11 to July 1 launch. Content ecosystem mature. No enrollment data until post-launch. No basis for movement. Next reassessment post-launch early July.
Counter-narrativePent-up demand among 14M eligible beneficiaries plus $50 copay plus no-opt-in-required framing plus mainstream media awareness plus automated adjudication breaks 1M ceiling by Dec 31
- https://www.cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-bridge
- https://www.obesityaction.org/changes-are-coming-medicare-access-to-glp-1-medications/
- https://www.medicareinteractive.org/understanding-medicare/medicare-prescription-drug-coverage-part-d/medicare-part-d-coverage/medicares-glp-1-bridge-program
- 2026-06-21 07:04 UTC · Ra runread brief →75%0· signal 60
Weekly review. T-10 to July 1 launch. Third-party content ecosystem mature. No enrollment data until post-launch. June 29-July 1 narrative collision: 503B comment close then PCAC oral deadline then Bridge launch — may crowd out Bridge coverage or create compelling contrast frame. Stoic: not actionable until post-launch enrollment data. Next reassessment early July.
Counter-narrativePent-up demand among 14M eligible beneficiaries plus $50 copay plus no-opt-in-required framing plus mainstream media awareness plus automated adjudication breaks 1M ceiling by Dec 31
- https://www.cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-bridge
- https://www.cms.gov/newsroom/press-releases/coming-soon-cms-provide-50-monthly-access-glp-1-medications-medicare-beneficiaries
- https://www.medicarerights.org/medicare-watch/2026/06/04/glp-1-weight-loss-drug-demonstration-begins-july-2026
- 2026-06-22 07:04 UTC · Ra runread brief →75%0· signal 60
T-9 to July 1 launch. CMS confirms prior authorizations accepted and processed starting July 1. No-opt-in framing. Content ecosystem mature. KARK local news affiliate coverage joins third-party ecosystem. No enrollment data until post-launch. Triple regulatory-calendar collision (503B June 29 + PCAC oral June 30 + Bridge July 1) may compete for or amplify media attention. Next reassessment post-launch early July.
Counter-narrativePent-up demand among 14M eligible beneficiaries plus $50 copay plus no-opt-in-required framing plus mainstream media awareness plus automated adjudication breaks 1M ceiling by Dec 31
- 2026-06-23 07:04 UTC · Ra runread brief →75%0· signal 60
T-8 to July 1 launch. The Hill published detailed Bridge explainer joining third-party content ecosystem alongside KFF MedicareInteractive CMS and local affiliates. No enrollment data until post-launch. Triple regulatory-calendar collision (503B June 29 + PCAC oral June 30 + Bridge July 1) may amplify or fragment media attention. Next reassessment post-launch early July.
Counter-narrativePent-up demand among 14M eligible beneficiaries plus $50 copay plus no-opt-in-required framing plus mainstream media awareness plus automated adjudication breaks 1M ceiling by Dec 31
- https://www.cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-bridge
- https://thehill.com/policy/healthcare/5931336-medicare-glp1-bridge-program/
- https://www.medicareinteractive.org/understanding-medicare/medicare-prescription-drug-coverage-part-d/medicare-part-d-coverage/medicares-glp-1-bridge-program
- 2026-06-24 07:04 UTC · Ra runread brief →75%0· signal 60
T-7 to July 1 launch. Content ecosystem mature across CMS KFF AMCP MedicareInteractive The Hill Humana local affiliates. PA forms operational. No enrollment data until post-launch. Triple regulatory-calendar collision June 29-July 1 may amplify or fragment media attention on Bridge. Next reassessment post-launch early July.
Counter-narrativePent-up demand among 14M eligible beneficiaries plus $50 copay plus no-opt-in-required framing plus mainstream media awareness plus automated adjudication breaks 1M ceiling by Dec 31
- 2026-06-25 07:04 UTC · Ra runread brief →75%0· signal 60
T-6 to July 1 launch. Content ecosystem mature. PA forms operational. No enrollment data until post-launch. Triple regulatory-calendar collision June 29-July 1 may compete for or amplify Bridge media attention. Boomer Benefits joined third-party content ecosystem. Next reassessment post-launch early July.
Counter-narrativePent-up demand among 14M eligible beneficiaries plus $50 copay plus no-opt-in-required framing plus mainstream media awareness plus automated adjudication breaks 1M ceiling by Dec 31
- 2026-06-26 07:04 UTC · Ra runread brief →75%0· signal 60
T-5 to July 1 launch. Medical Daily fine-print article and medicare.tools coverage joining ecosystem. Clinical eligibility narrowing confirmed: patients with T2D OSA MASH established CVD route to standard Part D not Bridge — Bridge serves weight-management-only pathway narrowing effective eligible pool. PA forms operational. No enrollment data until post-launch. Next reassessment post-launch early July.
Counter-narrativePent-up demand among 14M eligible beneficiaries plus $50 copay plus no-opt-in-required framing plus mainstream media awareness plus automated adjudication breaks 1M ceiling by Dec 31
- https://www.cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-bridge
- https://www.medicaldaily.com/medicare-glp1-bridge-program-july-2026-fine-print-limitations-475790
- https://www.medicare.tools/blog/medicare-coverage/who-is-eligible-for-glp-1-drugs-under-medicare-s-new-bridge-program
- 2026-06-27 07:04 UTC · Ra runread brief →75%0· signal 60
T-4 to July 1 launch. 503B extension removes competing compounding narrative from Bridge launch week — Bridge gets cleaner media attention. PA forms operational. Content ecosystem mature. No enrollment data until post-launch. Next reassessment post-launch early July.
Counter-narrativePent-up demand among 14M eligible beneficiaries plus $50 copay plus no-opt-in-required framing plus mainstream media awareness plus automated adjudication breaks 1M ceiling by Dec 31
- https://www.cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-bridge
- https://www.medicarerights.org/medicare-watch/2026/06/04/glp-1-weight-loss-drug-demonstration-begins-july-2026
- https://www.federalregister.gov/documents/2026/06/26/2026-12937/list-of-bulk-drug-substances-for-which-there-is-a-clinical-need-under-section-503b-of-the-federal
- 2026-06-28 07:04 UTC · Ra runread brief →75%0· signal 60
T-3 to July 1 launch. All operational: PA forms live FAQ published no opt-in required. Eligibility narrowing fully priced: T2D OSA MASH CVD patients route to standard Part D not Bridge. 503B extension removes competing narrative from launch week. Content ecosystem mature across 10+ third-party publishers. No enrollment data until post-launch. Next reassessment post-launch early July.
Counter-narrativePent-up demand among 14M eligible beneficiaries plus $50 copay plus no-opt-in-required framing plus mainstream media awareness plus automated adjudication breaks 1M ceiling by Dec 31
- https://www.cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-bridge
- https://www.sheppard.com/insights/blogs/medicares-50-per-month-glp1-bridge-what-you-need-to-know
- https://www.medicareinteractive.org/understanding-medicare/medicare-prescription-drug-coverage-part-d/medicare-part-d-coverage/medicares-glp-1-bridge-program
- 2026-06-29 07:04 UTC · Ra runread brief →75%0· signal 60
T-2 to July 1 launch. All operational. PA forms live FAQ published no opt-in required. Eligibility narrowing fully priced. 503B extension removes competing narrative from launch week. First real enrollment data arrives post-launch. Premortem this week: no-opt-in architecture genuinely novel for Medicare could eliminate activation-energy problem.
Counter-narrativePent-up demand among 14M eligible beneficiaries plus $50 copay plus no-opt-in-required framing plus mainstream media awareness plus automated adjudication breaks 1M ceiling by Dec 31
- https://www.cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-bridge
- https://www.cms.gov/newsroom/press-releases/coming-soon-cms-provide-50-monthly-access-glp-1-medications-medicare-beneficiaries
- https://www.medicareinteractive.org/understanding-medicare/medicare-prescription-drug-coverage-part-d/medicare-part-d-coverage/medicares-glp-1-bridge-program
- 2026-06-30 07:04 UTC · Ra runread brief →75%0· signal 60
T-1 to July 1 launch. MFN deal confirmed: Lilly and Novo committed to $245/mo manufacturer price for Medicare GLP-1s with $50 patient copay. CNN Hill KFF all covering launch. Bridge eligibility tiered: BMI 35+ standalone or BMI 30+ with HF/HTN/CKD or BMI 27+ with pre-diabetes/prior MI/stroke/PAD. Narrow but not trivially narrow. All operational. First enrollment data post-launch. Holding.
Counter-narrativePent-up demand among 14M eligible beneficiaries plus $50 copay plus no-opt-in-required framing plus mainstream media awareness plus MFN-backed manufacturer pricing breaks 1M ceiling by Dec 31
- https://www.cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-bridge
- https://www.pharmacytimes.com/view/eli-lilly-novo-nordisk-strike-mfn-deals-with-trump-administration-to-lower-glp-1-prices
- https://www.ajmc.com/view/trump-announces-deals-with-eli-lilly-novo-nordisk-for-lower-weight-loss-drug-prices
- 2026-07-01 07:04 UTC · Ra runread brief →75%0· signal 60
LAUNCH DAY. Bridge operational as of July 1. KFF analysis concretizes denominator: nearly 4M met eligibility criteria in 2023 not 14M. 1M enrollees = 25% penetration in 6 months — historically fast for any Medicare demonstration. Walgreens announced pharmacist readiness. PA forms operational. No enrollment data until mid-July at earliest. Holding.
Counter-narrativePent-up demand among eligible beneficiaries plus $50 copay plus no-opt-in-required architecture plus mainstream media awareness plus MFN-backed manufacturer pricing breaks 1M ceiling by Dec 31
- https://www.cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-bridge
- https://www.kff.org/medicare/nearly-four-million-medicare-beneficiaries-met-the-eligibility-criteria-in-2023-for-the-medicare-glp-1-bridge/
- https://corporate.walgreens.com/news-and-stories/press-releases/pharmacy-healthcare/walgreens-pharmacists-help-medicare-patients-navigate-new-access-to-glp-1-medications/
- 2026-07-02 07:04 UTC · Ra runread brief →75%0· signal 60
Day 2 post-launch. Program operational no technical failures no complaints. KFF denominator 4M eligible not 14M. 1M = 25% penetration in 6 months historically fast for Medicare demonstration. First enrollment data mid-July at earliest. Holding.
Counter-narrativePent-up demand among eligible beneficiaries plus $50 copay plus no-opt-in-required architecture plus mainstream media awareness plus MFN-backed manufacturer pricing breaks 1M ceiling by Dec 31
- https://www.cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-bridge
- https://www.kff.org/medicare/nearly-four-million-medicare-beneficiaries-met-the-eligibility-criteria-in-2023-for-the-medicare-glp-1-bridge/
- https://corporate.walgreens.com/news-and-stories/press-releases/pharmacy-healthcare/walgreens-pharmacists-help-medicare-patients-navigate-new-access-to-glp-1-medications/
- 2026-07-03 07:04 UTC · Ra runread brief →75%0· signal 60
Day 3 post-launch. Program operationally smooth. No technical failures no complaints no political blowback. KFF denominator refined: 3.8M met eligibility criteria in 2023. 1M = 26% penetration in 6 months historically fast for Medicare demonstration. No-opt-in architecture genuinely novel. AARP flagged implementation complexity but no problems surfaced. First enrollment data mid-July. Holding.
Counter-narrativePent-up demand among 3.8M eligible beneficiaries plus $50 copay plus no-opt-in-required architecture plus mainstream media awareness plus MFN-backed manufacturer pricing breaks 1M ceiling by Dec 31
- https://www.cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-bridge
- https://www.kff.org/medicare/nearly-four-million-medicare-beneficiaries-met-the-eligibility-criteria-in-2023-for-the-medicare-glp-1-bridge/
- https://www.medicaldaily.com/medicare-glp1-bridge-program-50-copay-eligibility-july-2026-475893
- 2026-07-04 07:04 UTC · Ra runread brief →75%0· signal 60
Day 4 post-launch. July 4 holiday. Program operationally smooth. CBS CNN Today AARP ran Bridge explainers around launch. First enrollment data mid-July. Holding.
Counter-narrativePent-up demand among 3.8M eligible plus $50 copay plus no-opt-in architecture plus mainstream media awareness breaks 1M ceiling by Dec 31
- 2026-07-05 07:04 UTC · Ra runread brief →75%0· signal 60
Day 5 post-launch. Holiday weekend data dead zone. New friction signals: 82% seniors unaware (CNBC June 28 pre-launch survey); LIS equity gap $50 copay for low-income (KFF); pharmacy processing confusion (Pharmacy Times AJMC). All support under-1M forecast. BALANCE shelved Bridge sole pathway through Dec 2027. First enrollment data expected July 7-11. Holding.
Counter-narrativePent-up demand among 3.8M eligible plus mainstream media awareness campaign overcomes awareness gap; pharmacies learn Bridge claims pathway within 2 weeks
- https://www.cnbc.com/2026/06/28/medicare-will-soon-cover-obesity-drugs-but-many-seniors-may-not-know.html
- https://www.kff.org/medicare/what-to-know-about-the-balance-model-for-glp-1s-in-medicare-and-medicaid/
- https://www.pharmacytimes.com/view/medicare-is-finally-covering-glp-1s-for-weight-loss-what-the-bridge-program-means-for-your-practice
- 2026-07-06 07:04 UTC · Ra runread brief →75%0· signal 60
Day 6 post-launch. Holiday weekend data dead zone. Program operationally smooth. GSC shows zero medicare-bridge queries hitting glp1picks. Pre-launch 82% awareness gap time-decaying after July 1 media blitz (CBS CNN WaPo AARP). First enrollment data expected July 7-11. Holding.
Counter-narrativePent-up demand among 3.8M eligible plus no-opt-in architecture plus mainstream media awareness campaign overcomes awareness gap and breaks 1M ceiling by Dec 31
- 2026-07-07 07:04 UTC · Ra runread brief →75%0· signal 60
Bridge launched July 1 on schedule; no enrollment data available — CMS typically reports quarterly with lag; KFF quantifies clinical-eligible pool at 3.8M (narrower than ~14M Part D obesity-diagnosed pool after eligibility-routing rules); 1M/3.8M = 26% uptake needed — achievable but above Medicare program base rates; holding 0.75
Counter-narrativePent-up demand from 3.8M clinical-eligible beneficiaries may drive faster-than-expected uptake once enrollment data becomes visible; prior auth friction may be lower than modeled if CMS streamlines processing
- 2026-07-08 07:04 UTC · Ra runread brief →75%0· signal 60
Day 8 post-launch; no enrollment data — CMS reports quarterly; absence of operational chaos headlines mildly positive; 82% pre-launch awareness gap time-decaying; first pharmacy claims volume data expected mid-July; holding 0.75
Counter-narrativePent-up demand among 3.8M eligible plus no-opt-in architecture plus $50/month for $1000+ drugs may overcome awareness gap and break 1M ceiling by Dec 31
- 2026-07-10 07:04 UTC · Ra runread brief →75%0· signal 60
Day 10 post-launch. No enrollment data — CMS reports quarterly. No operational failures no political blowback. First pharmacy claims volume data expected mid-July from trade press. KFF 3.8M eligible; 1M = 26% penetration in 6 months. Holding.
Counter-narrativePent-up demand among 3.8M eligible plus no-opt-in architecture plus mainstream media awareness plus $50 copay for $1000+ drugs may break 1M ceiling by Dec 31
- 2026-07-11 07:04 UTC · Ra runread brief →75%0· signal 60
Day 11 post-launch. No enrollment data — CMS reports quarterly. No operational failures no political blowback. Absence of failure headlines 11 days in mildly positive for smooth operations but not for high enrollment. First pharmacy claims data expected mid-to-late July. Holding.
Counter-narrativePent-up demand among 3.8M eligible plus no-opt-in architecture plus $50 copay for $1000+ drugs may break 1M ceiling by Dec 31
- https://www.cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-bridge
- https://www.ajmc.com/view/medicare-glp-1-bridge-launches-but-who-actually-qualifies-
- https://www.medicareinteractive.org/understanding-medicare/medicare-prescription-drug-coverage-part-d/medicare-part-d-coverage/medicares-glp-1-bridge-program
- 2026-07-12 07:04 UTC · Ra runread brief →75%0· signal 60
Day 12 post-launch. No enrollment data no operational failures no political blowback. Auto-eligible architecture confirmed. First pharmacy claims volume data expected mid-to-late July from trade press. Holding.
Counter-narrativePent-up demand among 3.8M eligible plus no-opt-in architecture plus mainstream media awareness plus $50 copay for $1000+ drugs may break 1M ceiling by Dec 31
- https://www.cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-bridge
- https://www.medicareinteractive.org/understanding-medicare/medicare-prescription-drug-coverage-part-d/medicare-part-d-coverage/medicares-glp-1-bridge-program
- https://www.kff.org/medicare/what-to-know-about-the-balance-model-for-glp-1s-in-medicare-and-medicaid/
- 2026-07-13 07:04 UTC · Ra runread brief →75%0· signal 60
Day 13 post-launch. No enrollment data no operational failures no political blowback. Auto-eligible confirmed. Multiple consumer guides now live indicating awareness building. First pharmacy claims data expected mid-to-late July. Holding.
Counter-narrativePent-up demand among 3.8M eligible plus auto-eligible architecture plus $50 copay for $1000+ drugs may break 1M ceiling by Dec 31
- 2026-07-14 07:04 UTC · Ra runread brief →75%0· signal 60
Day 14 post-launch. No enrollment data no operational failures no political blowback. Consumer guide proliferation across CMS Humana Medicare Interactive MyClearMatch indicates awareness diffusion. First pharmacy claims data expected mid-to-late July. Holding.
Counter-narrativePent-up demand among 3.8M eligible plus auto-eligible architecture plus $50 copay for $1000+ drugs may break 1M ceiling by Dec 31
- https://www.cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-bridge
- https://www.medicareinteractive.org/understanding-medicare/medicare-prescription-drug-coverage-part-d/medicare-part-d-coverage/medicares-glp-1-bridge-program
- https://www.humana.com/medicare/medicare-resources/does-medicare-cover-weight-loss-drugs
- 2026-07-15 07:04 UTC · Ra runread brief →75%0· signal 60
Day 15 post-launch. No enrollment data no operational failures no political blowback. The Hill mainstream explainer adds awareness. Medicare.gov/glp1bridge consumer portal live. First pharmacy claims data expected mid-to-late July. Holding.
Counter-narrativePent-up demand among 3.8M eligible plus auto-eligible architecture plus $50 copay for $1000+ drugs may break 1M ceiling by Dec 31
- https://www.cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-bridge
- https://thehill.com/policy/healthcare/5931336-medicare-glp1-bridge-program/
- https://www.medicareinteractive.org/understanding-medicare/medicare-prescription-drug-coverage-part-d/medicare-part-d-coverage/medicares-glp-1-bridge-program
- 2026-07-16 07:04 UTC · Ra runread brief →75%0· signal 60
Day 16 post-launch. No enrollment data no operational failures no political blowback. Consumer guide ecosystem maturing CMS Humana Medicare Interactive MyClearMatch. First pharmacy claims volume data expected mid-to-late July. Holding.
Counter-narrativePent-up demand among 3.8M eligible plus auto-eligible architecture plus $50 copay for $1000+ drugs may break 1M ceiling by Dec 31
- https://www.cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-bridge
- https://www.medicareinteractive.org/understanding-medicare/medicare-prescription-drug-coverage-part-d/medicare-part-d-coverage/medicares-glp-1-bridge-program
- https://www.humana.com/medicare/medicare-resources/does-medicare-cover-weight-loss-drugs
- 2026-07-17 07:04 UTC · Ra runread brief →75%0· signal 60
Day 17 post-launch. No enrollment data no operational failures no political blowback. Zero Medicare-bridge queries in GSC consistent with physician-initiated not consumer-searched program. First pharmacy claims data expected mid-to-late July. Holding.
Counter-narrativePent-up demand among 3.8M eligible plus auto-eligible architecture plus $50 copay for $1000+ drugs may break 1M ceiling by Dec 31
- https://www.cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-bridge
- https://www.medicareinteractive.org/understanding-medicare/medicare-prescription-drug-coverage-part-d/medicare-part-d-coverage/medicares-glp-1-bridge-program
- https://www.humana.com/medicare/medicare-resources/does-medicare-cover-weight-loss-drugs
- 2026-07-18 07:04 UTC · Ra runread brief →75%0· signal 60
Day 18 post-launch. No enrollment data no operational failures no political blowback. AARP consumer guide now live adding mainstream awareness. KFF confirms 3.8M eligible. First pharmacy claims data expected mid-to-late July. Holding.
Counter-narrativePent-up demand among 3.8M eligible plus auto-eligible architecture plus $50 copay for $1000+ drugs may break 1M ceiling by Dec 31
- https://www.cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-bridge
- https://www.aarp.org/medicare/glp1-weight-loss-copay-program/
- https://www.kff.org/medicare/nearly-four-million-medicare-beneficiaries-could-be-eligible-for-the-temporary-medicare-glp-1-bridge-program-covering-these-drugs-for-weight-loss/
- 2026-07-19 07:04 UTC · Ra runread brief →75%0· signal 60
Day 19 post-launch. No enrollment data no operational failures no political blowback. AARP guide live. Medicare.gov/glp1bridge portal operational. Zero consumer search demand in GSC. Physician-gated architecture consistent with quiet ramp. First pharmacy claims data expected mid-to-late July. Holding.
Counter-narrativePent-up demand among 3.8M eligible plus auto-eligible architecture plus $50 copay for $1000+ drugs may break 1M ceiling by Dec 31
- https://www.cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-bridge
- https://www.medicareinteractive.org/understanding-medicare/medicare-prescription-drug-coverage-part-d/medicare-part-d-coverage/medicares-glp-1-bridge-program
- https://www.aarp.org/medicare/glp1-weight-loss-copay-program/
- 2026-07-20 07:04 UTC · Ra runread brief →75%0· signal 60
Day 20 post-launch. No enrollment data, no operational failures, no political blowback, zero Medicare-bridge consumer search demand in GSC. Physician-gated quiet ramp intact. First pharmacy claims data expected late July. Holding.
Counter-narrativePent-up demand plus auto-eligible architecture plus $50 copay for $1000+ drugs could break the 1M ceiling by Dec 31
- 2026-07-21 07:04 UTC · Ra runread brief →75%0· signal 60
Day 21 post-launch. No enrollment data, no operational failures, zero Medicare-bridge consumer search demand in GSC. Physician-gated quiet-ramp architecture intact; KFF pegs ~3.8M eligible, and year-one Part D uptake base rates keep sub-1M dominant. First pharmacy claims data expected late July. Holding.
Counter-narrativePent-up demand across 3.8M eligible plus $50 copay on $1000+ drugs could break the sub-1M ceiling if CMS publishes an early-uptake surge
- https://www.cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-bridge
- https://www.ajmc.com/view/medicare-glp-1-bridge-launches-but-who-actually-qualifies-
- https://www.kff.org/medicare/nearly-four-million-medicare-beneficiaries-met-the-eligibility-criteria-in-2023-for-the-medicare-glp-1-bridge/
- 2026-07-22 07:04 UTC · Ra runread brief →75%0· signal 60
Day 22 post-launch. No enrollment data, no operational failures, near-zero Medicare-bridge consumer search demand in GSC (one query at position 52). First pharmacy claims data expected late July. Physician-gated quiet-ramp architecture intact; year-one Part D base rates keep sub-1M dominant. Holding.
Counter-narrativePent-up demand across 3.8M eligible plus a $50 copay on $1,000+ drugs plus auto-eligible architecture could break the 1M ceiling if CMS reports an early-uptake surge.
- https://www.cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-bridge
- morning-sources/first-party-pulse.md 2026-07-21 (GSC 7d)
- 2026-07-23 04:05 UTC · Ra runread brief →75%0· signal 60
Day 23 post-launch. CMS now cites ~3.4M eligible year one (vs KFF 3.8M); $245 net / $50 copay; Humana LI NET central processor. No enrollment data, no operational failures, near-zero bridge search demand in GSC. First pharmacy-claims data expected late July. Year-one Part D base rates keep sub-1M dominant. Holding.
Counter-narrativePent-up demand across ~3.4M eligible plus a $50 copay on $1,000+ drugs could break the 1M ceiling if CMS reports an early-uptake surge.
- 2026-07-24 04:04 UTC · Ra runread brief →75%0· signal 60
Day 24 post-launch; ~3.4M eligible confirmed, no enrollment data yet, first pharmacy-claims data expected late July. Year-one Part D base rates keep sub-1M dominant. Hold.
Counter-narrativePent-up demand plus a $50 copay on $1,000+ drugs could break the 1M ceiling if CMS reports an early-uptake surge.
- 2026-07-25 04:04 UTC · Ra runread brief →75%0· signal 60
Day 25 post-launch. No public enrollment data released; targeted search returned only program-structure pages, no figures. Near-zero bridge search demand in GSC. First pharmacy-claims data still pending. Year-one Part D base rates keep sub-1M dominant. Holding.
Counter-narrativePent-up demand across ~3.4M eligible plus a $50 copay on $1,000+ drugs could break the 1M ceiling if CMS reports an early-uptake surge.
- 2026-07-26 04:04 UTC · Ra run· flaggedread brief →66%-0.09· signal 62
Material disconfirming signal: CMS projects 800k-1.2M fill ATTEMPTS in July alone (MedicalDaily). Offsetting deflators: Bridge is weight-management-ONLY (comorbidity patients route to standard Part D), shrinking the true pool below 3.4M eligible; Part-D year-one base rate 10-15% favors sub-1M. Skeptic reads p(<1M)~0.50 on the projection; Historian base-rate ~0.78; Bayesian settles 0.66. FLAGGED: Skeptic/Bayesian divergence >=0.15 and projection contradicts the base-rate premise. Watch actual July fill data.
Counter-narrativeCMS own projection of 800k-1.2M July fill attempts, realized over six months of continuous enrollment, would push cumulative enrollees above 1M and falsify the sub-1M forecast.
- https://www.kff.org/medicare/nearly-four-million-medicare-beneficiaries-met-the-eligibility-criteria-in-2023-for-the-medicare-glp-1-bridge/
- https://www.medicaldaily.com/medicare-glp1-bridge-program-2026-balance-delay-coverage-2027-476283
- https://www.ajmc.com/view/medicare-glp-1-bridge-launches-but-who-actually-qualifies-
- 2026-07-27 04:15 UTC · Ra run· flaggedread brief →66%0· signal 62
Day 27 post-launch. Still no public enrollment or fill data released; CMS pages remain structure-only and targeted search returned no figures. First-party GSC shows near-zero medicare-bridge/wegovy-medicare demand. Holding 0.66. Standing Skeptic(~0.50 on the projection)/Bayesian(0.66) divergence >=0.15 persists pending actual July fill data -- flagged.
Counter-narrativeCMS's own 800k-1.2M July fill-attempt projection, realized over six months of continuous enrollment, would push cumulative enrollees above 1M and falsify the sub-1M forecast.
- https://www.cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-bridge
- https://www.ajmc.com/view/medicare-glp-1-bridge-launches-but-who-actually-qualifies-
- morning-sources/first-party-pulse.md 2026-07-26 (GSC: near-zero bridge/wegovy-medicare demand)
- 2026-07-28 04:05 UTC · Ra run· flaggedread brief →66%0· signal 62
Day 28. No public July enrollment/fill data; CMS confirms real-world numbers arrive in Q3 transparency reports and pages remain structure-only. First-party GSC shows near-zero medicare-bridge/wegovy-medicare demand -- a weak deflator on the pent-up-demand thesis. Standing Skeptic(~0.50 on projection)/Historian(~0.78 base rate)/Bayesian(0.66) divergence >=0.15 persists -- flagged. Watch first CMS July fill release, expected imminently.
Counter-narrativeCMS own 800k-1.2M July fill-attempt projection, realized over six months of continuous enrollment, would push cumulative enrollees above 1M and falsify the sub-1M forecast.
- https://www.cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-bridge
- https://www.ajmc.com/view/medicare-glp-1-bridge-launches-but-who-actually-qualifies-
- morning-sources/first-party-pulse.md 2026-07-27 (GSC: near-zero bridge demand)
- 2026-07-29 04:20 UTC · Ra run· flaggedread brief →66%0· signal 61
Day 29. No public July enrollment or fill data; CMS pages remain structure-only and Beckers still lists the open operational questions. Humana/LI NET is the central processor, real-world numbers arrive in Q3 transparency reports. First-party GSC shows near-zero bridge demand. Held 0.66. Standing Skeptic(~0.50 on the CMS projection)/Historian(~0.78 Part-D year-one base rate)/Bayesian(0.66) divergence >=0.15 persists -- flagged.
Counter-narrativeCMS own 800k-1.2M July fill-attempt projection, realized over six months of continuous enrollment, would push cumulative enrollees above 1M and falsify the sub-1M forecast.
- https://www.cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-bridge
- https://www.beckershospitalreview.com/glp-1s/cms-launches-the-medicare-glp-1-bridge-but-4-questions-linger/
- morning-sources/first-party-pulse.md 2026-07-28 (GSC: near-zero bridge demand)
- 2026-07-30 04:10 UTC · Ra run· flaggedread brief →66%0· signal 60
Day 30 -- month one of the demonstration closes today and the program has produced no public enrollment or fill figure of any kind. CMS pharmacy/provider/prescriber pages remain operational-structure only; AHIP and Beckers still frame open questions rather than results. First-party GSC top-15 queries are 100% Embody/tirzepatide with zero medicare-bridge or wegovy-medicare terms. Signal strength trimmed 61->60: thirty days of total data absence is a decaying evidence set, not a stable one. Held 0.66. Standing Skeptic(~0.50 on the CMS projection)/Historian(~0.78 Part-D year-one base rate)/Bayesian(0.66) divergence >=0.15 persists -- flagged. Next real trigger is the Q3 transparency report via Humana/LI NET.
Counter-narrativeCMS own 800k-1.2M July fill-attempt projection, realized over six months of continuous enrollment, would push cumulative enrollees above 1M and falsify the sub-1M forecast.
- https://www.cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-bridge
- https://www.cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-bridge/information-pharmacies
- https://www.ahip.org/news/articles/cms-medicare-glp-1-bridge-what-to-know
- morning-sources/first-party-pulse.md 2026-07-29 (GSC: zero bridge/medicare queries in top-15)
- 2026-07-31 04:15 UTC · Ra run· flaggedread brief →66%0· signal 59
Day 31 and month one of the demonstration closes today with no public enrollment or fill figure of any kind. CMS pages remain structure-only; the trade press is still asking who qualifies rather than reporting who enrolled. Signal strength 60 to 59: an evidence set that is a month of pure absence decays rather than holds. Historian Part-D year-one base rate near 0.78 and Skeptic near 0.50 on the CMS projection still diverge past 0.15, so flagged for a fourth run. Next real trigger is the Q3 transparency report.
Counter-narrativeCMS own 800k-1.2M July fill-attempt projection, realized over six months of continuous enrollment, would push cumulative enrollees above 1M and falsify the sub-1M forecast.
- https://www.cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-bridge
- https://www.medicarerights.org/medicare-watch/2026/06/04/glp-1-weight-loss-drug-demonstration-begins-july-2026
- https://www.beckershospitalreview.com/glp-1s/cms-launches-the-medicare-glp-1-bridge-but-4-questions-linger/
- morning-sources/first-party-pulse.md 2026-07-30 (GSC top-15 carries zero bridge or medicare queries)
- 2026-08-01 04:12 UTC · Ra run· flaggedread brief →63%-0.03· signal 68
TWO corrections pulling opposite ways, net -0.03. First, the denominator in this forecast's own note is wrong: it reasons from 14M eligible, but KFF's claims-based analysis puts Bridge-eligible Part D enrollees at 3.8M and CMS's own year-one estimate is 3.4M. The 13M-plus figure is the broader Medicare obesity-and-overweight population, a different set. The 1M bar is therefore about 26 percent of eligible, not 7 percent, which makes the forecast HARDER to falsify. Second and larger, the CMS 800k-1.2M July projection is now corroborated rather than a trade-press assertion, and it sits against that same 3.4M, so the agency itself models a 24-35 percent month-one attempt rate; attempts are not enrollees, with prior auth and clinician attestation in between, but the agency's own model points above the threshold. SEPARATELY AND MORE IMPORTANT: this forecast names official CMS Part D enrollment data as its resolution source, and KFF confirms the Bridge operates OUTSIDE the Part D benefit and payment system, so the named source structurally cannot report the quantity forecast. Unresolvable as written on 2026-12-31 and needs operator repair. Historian 0.80 on demonstration year-one base rates, Skeptic 0.45 on the CMS projection, divergence 0.35, fifth consecutive flag and now wider rather than narrower. Signal strength 59 to 68 on source quality; still zero actual enrollment data at day 32.
Counter-narrativeCMS projects 800,000 to 1.2 million fill attempts in July alone against a 3.4M year-one eligible pool, and six further months of enrollment on top of a month-one cohort that size clears 1M comfortably.
- https://www.kff.org/medicare/nearly-four-million-medicare-beneficiaries-met-the-eligibility-criteria-in-2023-for-the-medicare-glp-1-bridge/ (KFF, published 2026-06-29, fetched at primary source)
- https://www.beckershospitalreview.com/glp-1s/cms-launches-the-medicare-glp-1-bridge-but-4-questions-linger/
- https://www.cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-bridge (structure only, no enrollment figure)
- https://www.ajmc.com/view/medicare-glp-1-bridge-launches-but-who-actually-qualifies-
- 2026-08-02 04:15 UTC · Ra run· flaggedread brief →63%0· signal 68
Held at 0.63, day 33, still no enrollment figure published anywhere. Nothing new bears on the numerator. Today's primary-source read bears on resolvability: KFF confirms at source that the Bridge sits outside Part D by design, and that it now runs to 2027-12-31, so there is no reporting event scheduled at the forecast's own resolution date. Declining to re-price the 2027 extension, which has been in the prior since 2026-04-27. Historian 0.80 against Skeptic 0.45, divergence 0.35, sixth consecutive flagged run.
Counter-narrativeCMS own 800k-1.2M July fill-attempt projection against a 3.4M year-one eligible pool models a 24-35 percent month-one attempt rate, which realized over eighteen months would carry cumulative enrollment above the 1M bar.
- https://www.kff.org/medicare/what-to-know-about-the-balance-model-for-glp-1s-in-medicare-and-medicaid/ (KFF, updated 2026-05-11, fetched at primary source HTTP 200: the Bridge is a Section 402 demonstration separate from Part D, Part D sponsors neither opt in nor bear financial risk, extended through 2027-12-31)
- https://www.forbes.com/sites/joshuacohen/2026/08/01/medicares-glp-1-bridge-program-offers-access-but-isnt-straightforward/ (HTTP 200, headline and byline verified, body figures not extracted)
- https://www.cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-bridge
- 2026-08-03 04:15 UTC · Ra run· flaggedread brief →63%0· signal 68
Held at 0.63, day 34, no enrollment figure published. Today the negative is checked at the source rather than inferred: the CMS newsroom index itself was fetched HTTP 200 and its six most recent items are all unrelated payment rules. Nothing bears on the numerator. The resolvability defect stands unchanged from 2026-08-02 and is an operator decision, not a probability one. Historian 0.80 against Skeptic 0.45, divergence 0.35, seventh consecutive flagged run.
Counter-narrativeCMS own 800k-1.2M July fill-attempt projection against a 3.4M year-one eligible pool models a 24-35 percent month-one attempt rate, which realized over eighteen months would carry cumulative enrollment above the 1M bar.
- https://www.cms.gov/newsroom (HTTP 200, fetched at primary source: six most recent items dated 2026-07-29 to 2026-07-31 cover joint replacement, FY2027 IPPS, hospice, IRF, IPF and SNF final rules - no Bridge enrollment release)
- https://www.cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-bridge
- https://www.kff.org/medicare/what-to-know-about-the-balance-model-for-glp-1s-in-medicare-and-medicaid/ (Section 402 demonstration separate from Part D, runs to 2027-12-31, verified at primary source 2026-08-02)
- 2026-08-04 04:15 UTC · Ra run· flaggedread brief →63%0· signal 68
Held at 0.63, day 35, no enrollment figure published. The CMS newsroom index was fetched at primary source and has published one new item since yesterday, on health-technology infrastructure, nothing touching the numerator. A Forbes health-policy column on Bridge friction dated 2026-08-01 was fetched but its body was never reached, so it is logged unverified rather than cited. The resolvability defect stands unchanged and is an operator decision, not a probability one. Historian 0.80 against Skeptic 0.45, divergence 0.35, eighth consecutive flagged run.
Counter-narrativeCMS's own 800k-1.2M July fill-attempt projection against a 3.8M year-one eligible pool models a 21-32 percent month-one attempt rate, which realized over eighteen months would carry cumulative enrollment above the 1M bar.
- https://www.cms.gov/newsroom (agent-fetch run 30876911527, HTTP 200, redirected to /about-cms/contact/newsroom: most recent item is Aug 03 2026 'Readout: CMS Celebrates Delivery of the Health Technology Ecosystem, One Year After Launch', followed by the Jul 31 joint-replacement expansion and the FY2027 IPPS, hospice, IRF and IPF final rules - no Bridge enrollment release)
- https://www.kff.org/medicare/what-to-know-about-the-balance-model-for-glp-1s-in-medicare-and-medicaid/ (3.8M eligible denominator, Section 402 demonstration separate from Part D, verified at primary source 2026-08-02)
- https://www.forbes.com/sites/joshuacohen/2026/08/01/medicares-glp-1-bridge-program-offers-access-but-isnt-straightforward/ (agent-fetch run 30877028979, HTTP 200 and 1.34MB but the 9000-char extract returned Forbes site navigation only; body NOT read and NOT used)
- 2026-08-05 04:15 UTC · Ra run· flaggedread brief →63%0· signal 68
Ninth consecutive hold. Day 36 with no numerator published and no CMS release touching it. The row's real defect is unchanged and is now 36 days old: it names official CMS Part D enrolment data as its resolution source while the Bridge operates outside Part D by design, so the named source structurally cannot report the quantity. Historian 0.80 against Skeptic 0.45, divergence 0.35, flagged. Today's Medicaid expansion in Indiana is a coverage-direction signal and explicitly not a Medicare one; I am recording it so a later run does not mistake it for numerator movement.
Counter-narrativePent-up demand plus aggressive CMS outreach could still clear 1M in the six-month window, and a silent newsroom at day 36 is consistent with both a fast programme and a slow one because CMS was never going to publish enrolment monthly.
- https://www.cms.gov/newsroom (agent-fetch run 30974432502, HTTP 200, 50,527 bytes, redirected to /about-cms/contact/newsroom: newest items are Aug 04 on an autism/ABA state toolkit, Aug 03 on the Health Technology Ecosystem and Jul 31 on joint-replacement expansion - no Bridge enrolment release)
- data/news/2026-08-04.json gnews-glp1-coverage SECONDARY, 2026-08-04: Indiana Gov. Braun announces a state MEDICAID GLP-1 coverage program, which sits outside this forecast's Medicare numerator entirely
- 2026-08-06 04:15 UTC · Ra run· flaggedread brief →63%0· signal 68
Tenth consecutive run with no numerator. The one new item is a county government explainer page, which is a distribution signal and not an enrolment signal; logged so a later run does not mistake it for movement. Day 37 on the standing operator decision that this row's named resolution source cannot structurally report the quantity, because the Bridge operates outside the Part D benefit by design. Historian 0.80 against Skeptic 0.45, divergence 0.35, flagged on divergence rather than on delta.
Counter-narrativeSustained county-level and state-level explainer activity is what precedes an enrolment surge, and a single quiet CMS newsroom is not evidence of a slow programme.
- https://www.cms.gov/newsroom (agent-fetch run 31070681710, HTTP 200, 50527 bytes, redirected to /about-cms/contact/newsroom: newest items are Aug 04 on a state autism/ABA toolkit, Aug 03 on the Health Technology Ecosystem readout and Jul 31 on the joint-replacement expansion, then the FY2027 IPPS, hospice and IRF final rules - no Bridge enrolment release)
- data/news/2026-08-05.json gnews-glp1-coverage (Tier 0, on disk: Chautauqua County NY .gov published Understanding the Medicare GLP-1 Bridge Program on 2026-08-05)
- 2026-08-07 04:15 UTC · Ra run· flaggedread brief →63%0· signal 68
Nothing moved, day 38. The row remains flagged on Historian 0.80 against Skeptic 0.45, and the deeper problem is unchanged since 2026-08-01: the named resolution source is Part D enrolment data and the Bridge operates outside the Part D benefit by design, so the row is unresolvable as written.
Counter-narrativeA single CMS enrolment release could settle this in one publication and the agency has given no indication of its cadence, so eleven runs of silence is weak evidence about the number rather than strong evidence about it.
- https://www.cms.gov/newsroom (agent-fetch run 31146638435, HTTP 200, 50527 bytes, redirected to /about-cms/contact/newsroom: newest items are Aug 04 on a state autism/ABA toolkit, Aug 03 on the Health Technology Ecosystem readout and Jul 31 on the joint-replacement expansion, then the FY2027 IPPS, hospice and IRF final rules - no Bridge enrolment release)
- data/news/2026-08-07.json fr-semaglutide and fr-tirzepatide (Tier 0 on disk, PRIMARY, both zero items)
- 2026-08-08 04:15 UTC · Ra run· flaggedread brief →57%-0.06· signal 74
Largest move on this row in eleven runs and the first that is not about CMS silence. Amazon Pharmacy went live as a participating Bridge pharmacy on 2026-08-06 with eligibility, prior authorization and billing automated and same-day delivery in 3,100-plus cities, with CVS and Walmart reported competing; that removes exactly the formulary-navigation and re-prescribing friction the original row named as its reason for a slow year one. The verified counterweight, new today, is that the program is narrower than the coverage suggests: weight-loss indication only, comorbid patients carved out even when their plan denied the drug, PA on every first fill, no 90-day supplies, and the $50 outside the deductible and the out-of-pocket cap. Net -0.06. Also the cleanest confirmation yet of the standing unresolvability finding: Bridge adjudicates on its own BIN/PCN and is stated to be separate from regular Part D coverage, so official CMS Part D enrolment data structurally cannot report this quantity. STEP V caught a live discrepancy before the order shipped and it is corrected in the row: Amazon's FAQ lists the disqualifying diagnoses as type 2 diabetes, heart disease, sleep apnea and liver disease, while a WebSearch summary of the CMS Bridge page renders them as type 2 diabetes, moderate-to-severe sleep apnea and fatty liver disease with no heart disease; neither is publishable and the order now instructs the resolver to read the CMS page. The CMS release also sharpens the unresolvability finding rather than softening it: this is a demonstration billing on its own rail, so Part D enrolment files are the wrong instrument even though every enrollee is a Part D member.
Counter-narrativeThe pharmacy counter was never the binding constraint on enrolment - the comorbidity carve-out and the prior-authorization gate are - so a distribution story can look like an uptake story while the eligible pool stays at 3.8M and the six-month window stays short.
- https://www.aboutamazon.com/news/retail/amazon-pharmacy-glp-1-medicare (agent-fetch run 31238811859, HTTP 200, 202355 bytes: Amazon Pharmacy now delivers Wegovy injectable and oral pill, Zepbound KwikPen and Foundayo to eligible Medicare Part D patients at $50 a month with free home delivery, Same-Day Delivery in more than 3,100 US cities and towns expanding to nearly 4,500 by end of 2026, no Prime required, and Amazon automates eligibility verification, prior authorization and billing)
- https://pharmacy.amazon.com/medicare-glp-1-bridge-program-details (same run, HTTP 200, 122119 bytes: Bridge started 2026-07-01 and runs through 2027-12-31; covers Wegovy, Zepbound KwikPen and Foundayo for weight loss only with Ozempic and Mounjaro excluded; 28- or 30-day supplies only, no 90-day fills and no pen needles; first fill requires a prior authorization decided typically within 72 hours; the $50 does not count toward the Part D deductible or the annual out-of-pocket cap; ineligible if a diagnosis such as type 2 diabetes, heart disease, sleep apnea or liver disease makes the GLP-1 coverable under the existing Part D plan even where the plan did not actually cover it; separate claims rail, BIN 028918 PCN MEDDGLP1BR)
- https://www.cms.gov/newsroom (same run, HTTP 200, 50560 bytes, redirected to /about-cms/contact/newsroom: newest are the Aug 07 device-coverage procedural notice CMS-3487-NC, the Aug 04 autism/ABA state toolkit and the Aug 03 Health Technology Ecosystem readout - no Bridge enrolment release, twelfth consecutive run of silence)
- https://www.cms.gov/newsroom/press-releases/cms-launches-medicare-glp-1-bridge-expanding-access-glp-1-medications (agent-fetch run 31239108639, HTTP 200, 56088 bytes, CMS press release dated 2026-07-01: eligible individuals enrolled in Medicare Part D prescription drug coverage may obtain certain GLP-1s at $50 per month through 2027-12-31; CMS frames the initiative as designed to test the impacts of increased access to GLP-1 drugs for weight management on the Medicare program, i.e. a demonstration; and states not all beneficiaries qualify including those who already receive GLP-1s through existing Medicare drug coverage OR ARE ELIGIBLE FOR GLP-1 coverage through the Part D benefit - the carve-out is CMS's, not Amazon's)
- https://www.cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-bridge and /information-pharmacies (same run, both HTTP 200, 222495 and 257715 bytes; body truncated behind site navigation in a 12000-char window, so the per-diagnosis exclusion list was NOT read at CMS this run)
- 2026-08-09 04:18 UTC · Ra run· flaggedread brief →55%-0.02· signal 75
-0.02 on CVS becoming a second national retail channel five days after Amazon, which removes more of the formulary-navigation and re-prescribing friction the original row named as its reason for a slow year one. Kept small deliberately because the CVS item is SECONDARY-tier only and because the smaller verified denominator pushes the other way; the two effects are close to cancelling and the honest move is a small step, not the -0.06 that yesterday's Amazon primary earned. Day 39 on the standing unresolvability finding, unchanged and now sharper: the Bridge adjudicates on its own BIN 028918 PCN MEDDGLP1BR rail as a demonstration, so official CMS Part D enrolment data structurally cannot report this quantity. Flagged on Historian 0.80 against Skeptic 0.45, divergence 0.35, not on delta.
Counter-narrativeThe pharmacy counter was never the binding constraint and the verified denominator cuts the other way: on a 3.8M eligible pool the 1,000,000 threshold is 26 percent of eligible in six months, not the 7 percent of 14M the original row modelled, and the comorbidity carve-out plus prior authorisation on every first fill plus weight-loss-indication-only remain untouched.
- https://www.cms.gov/newsroom (agent-fetch run 31294014846, HTTP 200, 50560 bytes, redirected to /about-cms/contact/newsroom: newest are the Aug 07 device-coverage procedural notice CMS-3487-NC, the Aug 04 autism/ABA state toolkit and the Aug 03 Health Technology Ecosystem readout - no Bridge enrolment release, thirteenth consecutive run of silence)
- data/news/2026-08-08.json gnews-glp1-coverage (Tier 0, SECONDARY): Drug Store News and Investing.com 2026-08-05, CVS Health revamps its weight-management programme for GLP-1 access and expands GLP-1 offerings with Lilly; Atlanta News First, Seeking Alpha and NewsBreak 2026-08-06 to 08-08 carrying the Amazon Bridge launch; magicvalley.com 2026-08-08 'Medicare to cover GLP-1 during a bridge period, Part 2'
- data/news/2026-08-08.json fr-semaglutide and fr-tirzepatide (Tier 0, PRIMARY, both zero items)
- 2026-08-10 04:15 UTC · Ra runread brief →55%0· signal 75
Held at 0.55, delta 0. Nothing new: the CMS newsroom index is byte-for-byte the same story set as yesterday and the Amazon Part D item is the 2026-08-06 fact still echoing through secondary outlets, not a second event. Under the rule set on 2026-08-09 a standing absence re-measured is not an update, so the row does not move. Day 40 on the unresolvability finding: the Bridge runs on its own BIN/PCN rail as a demonstration outside Part D, so the resolution source named in the forecast structurally cannot report the quantity, and this remains an operator decision.
Counter-narrativeTwo national retail channels inside a week (Amazon 2026-08-06, CVS five days later) removed most of the formulary friction the original row named as its reason for a slow year one, and nothing in the last two days speaks against that.
- 2026-08-11 04:16 UTC · Ra runread brief →55%0· signal 75
Held at 0.55, delta 0. The CMS newsroom did move today, for the first time in three runs, and it moved to a Washington state emergency notice - which is the cleanest possible demonstration that the channel is live and simply has nothing to say about the Bridge. Day 41 on the unresolvability finding: the Bridge runs on its own BIN/PCN rail as a demonstration outside Part D, so the CMS Part D enrolment data named in the row structurally cannot report the quantity, and the row stays unresolvable as written after sixteen Ra runs of probability work.
Counter-narrativeTwo national retail channels inside a week removed most of the formulary friction the original row named as its reason for a slow year one, and nothing in the last three days speaks against that.
- https://www.cms.gov/newsroom (agent-fetch run 31457706167, HTTP 200, 50490 bytes, redirected to /about-cms/contact/newsroom: one new item since yesterday, the Aug 10 news alert on public health emergency flexibilities in Washington state, plus the unchanged Aug 07 device-coverage procedural notice CMS-3487-NC, the Aug 04 autism/ABA state toolkit and the Aug 03 Health Technology Ecosystem readout - no Bridge enrolment release, fifteenth consecutive run)
- data/news/2026-08-10.json gnews-glp1-coverage (Tier 0, SECONDARY): ConsumerAffairs 2026-08-10 'CVS expands weight-loss program with $29 online visits and new GLP-1 options', which is coverage of the 2026-08-07 expansion rather than a second event
- data/news/2026-08-10.json fr-semaglutide and fr-tirzepatide (Tier 0, PRIMARY, both zero items)
- 2026-08-12 04:15 UTC · Ra runread brief →55%0· signal 75
CMS newsroom answered and had nothing to say about the Bridge for a 16th consecutive run. Day 42 on the unresolvability finding: the Bridge operates outside Part D by design, so the named resolution source structurally cannot report the quantity. The orforglipron 65-plus post hoc (ATTAIN-1 Week 72, -13.0% at 17.2 mg vs -1.6% placebo) is real evidence about Medicare-age demand and no evidence at all about 2026 enrolment, so it is filed and not applied.
Counter-narrativeAn oral GLP-1 with confirmed Week-72 efficacy in the 65-plus group raises the demand ceiling on the Bridge, and pent-up demand plus a retail channel could clear 1M faster than a year-one base rate implies.
- 2026-08-13 04:15 UTC · Ra runread brief →55%0· signal 75
Seventeenth consecutive verified-negative on the CMS newsroom. Day 43 on the unresolvability finding logged 2026-08-01. The Lilly direct-to-Medicare item, if it holds up at primary, makes this row harder to resolve rather than likelier, because it is one more channel operating outside the Part D data the forecast names as its resolution source. Not fetched, so it changes nothing today.
Counter-narrativeAggressive CMS outreach plus pent-up demand could still drive faster-than-normal year-one uptake, but no enrolment figure has been published to test it either way.
- https://www.cms.gov/newsroom (agent-fetch run 31666181822, HTTP 200, 49221 bytes, redirected to /about-cms/contact/newsroom: latest items 2026-08-11 Medicaid/CHIP, 2026-08-10 Washington PHE, 2026-08-07 CMS-3487-NC; nothing on the Bridge)
- data/news/2026-08-12.json gnews-glp1-coverage (Lilly $50/month Medicare access, simplywall.st 08-12, SECONDARY, NOT taken to primary)
- 2026-08-14 04:15 UTC · Ra runread brief →55%0· signal 75
Held. Day 44 on the unresolvability finding logged 2026-08-01: the Bridge operates outside Part D by design, so the resolution source the row names structurally cannot report the quantity. No CMS item in today's digest. The one Medicare-adjacent item, a Salem Reporter column on a trial offering Medicare recipients GLP-1 drugs without a diagnosis, is SECONDARY, is about a trial rather than Bridge enrolment, and was not taken to primary because it cannot move this row either way. Eighteenth consecutive run with nothing to apply.
Counter-narrativeCMS could publish a mid-year enrolment figure at any time and collapse the unresolvability finding in one release.
- data/news/2026-08-13.json gnews-glp1-coverage
- https://www.federalregister.gov/api/v1/documents.json?conditions[term]=bulk+drug+substances+compounding&conditions[publication_date][gte]=2026-07-23
- 2026-08-15 04:15 UTC · Ra runread brief →62%+0.07· signal 80
Up 0.07 on evidence this log gathered seven days ago and never applied to the forecast. The CMS carve-out verified 2026-08-08 for a work-order disqualifies beneficiaries who ALREADY receive GLP-1s under Part D or ARE ELIGIBLE for Part D GLP-1 coverage, which cuts the denominator well below the 14M the original note assumed; a smaller eligible pool makes fewer-than-1M more likely, and the action layer knew it while the forecast layer held 0.55. Today's Amazon channel activation pushes the other way and is why the move is 0.07 and not larger. Skeptic sits near 0.50 against the Bayesian's 0.62, a 0.12 divergence, the widest of the run and short of the flag line. CMS still publishes no enrolment figure, day 45.
Counter-narrativeA national retail channel with automated eligibility, prior-auth and same-day delivery in 3,100-plus cities is exactly the friction removal that breaks a year-one Part D uptake base rate, and Amazon plus Lilly are both now marketing the $50 price directly.
- https://www.cms.gov/newsroom (agent-fetch run 31863683221, HTTP 200, 49221 bytes, redirect to /about-cms/contact/newsroom; latest items 2026-08-11 Medicaid/CHIP sex-rejecting-procedures, 2026-08-10 Washington PHE, 2026-08-07 CMS-3487-NC, 2026-08-04 autism toolkit; NO Bridge enrolment item, day 45)
- https://news.google.com/rss/search?q=Lilly+%22%2450%22+Medicare+obesity+when:14d (agent-fetch run 31863683221, HTTP 200, 14890 bytes: The Pharma Letter 2026-08-07 'Amazon Pharmacy starts filling $50 Medicare GLP-1 prescriptions', NCOA 2026-08-07 Bridge explainer, simplywall.st 2026-08-12 Lilly $50 Medicare access)
- work-orders.tsv glp1picks-update-bridge-retail-channel-and-carveouts (CMS carve-out verified 2026-08-08, cms.gov/newsroom/press-releases/cms-launches-medicare-glp-1-bridge-expanding-access-glp-1-medications)
- 2026-08-16 04:15 UTC · Ra runread brief →62%0· signal 80
Held. The only new evidence is consumer-awareness media (Motley Fool 08-15, WGAL 08-13); pricing an enrolment forecast off coverage volume is failure case F1 (Google Flu Trends) by construction. CMS fetched clean at 200 and still publishes no enrolment figure: day 46.
Counter-narrativeA $50 flat copay plus Amazon Pharmacy fulfilment plus a national consumer-press wave is a distribution stack, not mere coverage, and could clear 1M inside the six-month window.
- 2026-08-17 04:25 UTC · Ra runread brief →65%+0.03· signal 80
CMS newsroom fetched clean at HTTP 200 and 49221 bytes with no Bridge enrolment item, day 47. Two deliberately weak positives: agencies publicise good enrolment, so seven weeks of silence after a July 1 launch is mildly consistent with under-target uptake; and Medicare negotiated 2027 prices take effect 2027-01-01, after the resolution date, giving a rational beneficiary a reason to defer, though that is a different programme from the Bridge and the mechanism is thin. Pricing this forecast off coverage volume remains failure case F1.
Counter-narrativeA 50 dollar copay plus Amazon fulfilment plus sustained national press is a distribution stack rather than mere coverage, and CMS silence on an interim figure is not the same as a low figure.
- https://www.cms.gov/newsroom
- data/news/2026-08-17.json gnews-glp1-drugs
- 2026-08-18 04:15 UTC · Ra runread brief →70%+0.05· signal 82
Up 0.05 on the first named-outlet reporting about enrolment FRICTION rather than coverage or awareness, which matters because friction is the mechanism the under-1M base rate rests on and because it is the first evidence on this row that is not failure case F1. STAT is a Tier 1 trade outlet and the item is reported news, not opinion. It has been on disk in data/news/2026-08-11.json under gnews-glp1-coverage for seven days, through six runs, including the 2026-08-14 row that recorded 'no CMS item in today's digest' and 'nothing to apply' while it sat three days old in the same directory. That is the second instance in four days of on-disk evidence going unpriced and the repair is in section 4 as a mechanical amendment rather than an intention. Skeptic near 0.58 against Bayesian 0.70, divergence 0.12, under the flag line. CMS answered clean and still publishes no enrolment figure: day 48.
Counter-narrativeA 50 dollar copay plus Amazon Pharmacy fulfilment plus a sustained national awareness wave is a distribution stack that has broken year-one Part D base rates before, and one trade report on paperwork does not measure how many people completed it anyway.
- https://news.google.com/rss/search?q=%22Medicare%22+GLP-1+bridge+enrollment+when:7d (agent-fetch run 32097971346, HTTP 200, 12934 bytes: STAT 2026-08-11 'Burdensome Medicare GLP-1 program may keep patients from accessing $50 per month weight loss drugs'; NewsNation explainer 2026-08-18; Employee Benefit News 2026-08-14)
- data/news/2026-08-11.json gnews-glp1-coverage (same STAT item, on disk since 2026-08-11, unpriced for seven runs)
- https://www.cms.gov/newsroom (agent-fetch run 32097971346, HTTP 200, 49221 bytes, redirect to /about-cms/contact/newsroom, latest items 2026-08-11 Medicaid/CHIP, 2026-08-10 Washington PHE, 2026-08-07 CMS-3487-NC, 2026-08-04 autism toolkit; NO Bridge enrolment item, day 48)
- 2026-08-19 04:15 UTC · Ra runread brief →70%0· signal 80
Held at 0.70 on no evidence of the kind that moves this row. All four of today's Bridge items are consumer explainers, which is failure case F1 exactly: coverage volume is not the forecast quantity and pricing this row off it is the named error. Said plainly because the scorecard has to agree with it: CMS newsroom was NOT re-fetched this run, the fetch budget having gone to the FTC primary and the U.S. News verification, so today is a hold on absent new information rather than on a source checked and found empty. Yesterday's day-48 CMS check stands as the last measurement. The structural problem logged on 2026-08-01 is untouched and is still the largest thing wrong with this row: the named resolution source is official CMS Part D enrolment data, and the Bridge operates outside the Part D benefit and payment system by design, so no amount of probability work makes the row resolvable as written.
Counter-narrativeA 50 dollar copay plus Amazon Pharmacy fulfilment plus a sustained national awareness wave is a distribution stack that has broken year-one Part D base rates before, and four explainers in three days is evidence of reach even though it is not evidence of enrolment.
- data/news/2026-08-18.json gnews-glp1-coverage (Yahoo 2026-08-17 and NewsNation 2026-08-18 'What is Medicare's GLP-1 Bridge program?'; Cone Health 2026-08-18 'Medicare Calls it a Bridge Program'; AOL 2026-08-16 'Medicare Launched a New Program Last Month That Could Lead to Big Savings for Seniors')
- data/news/2026-08-18.json openfda-shortages-glp1 (5 items, all Liraglutide Injection Novo Nordisk, date_kind shortage_updated 08/17/2026, no Bridge content)
- 2026-08-20 04:15 UTC · Ra runread brief →70%0· signal 80
Hold on absent information, stated plainly so the scorecard agrees: CMS newsroom was not fetched this run for a second consecutive day, the fetch budget having gone to two ClinicalTrials.gov primaries and the Federal Register. Today's three items are a retail-channel item and two political-pricing items - failure case F1 again, since coverage volume is not the forecast quantity. Day-49 check on the enrollment question stands unmade.
Counter-narrativeA 50 dollar copay against a retail channel that keeps widening is the case for blowing through a million enrollees, and nothing checked today can see enrollment either way.
- data/news/2026-08-19.json gnews-glp1-coverage (AOL 2026-08-19 'Costco's first Medicare partnership targets senior care experience'; AOL 2026-08-19 'Bernie Sanders Says His Medicare Plan Would Save Lives and $1 Trillion a Year')
- data/news/2026-08-19.json gnews-glp1-brands (TechStock2 2026-08-19 'Novo Nordisk Shares (NYSE:NVO) Gain 1.9% as $50 Medicare Wegovy Access Trial Challenges Pricing')
- 2026-08-21 04:15 UTC · Ra run· flaggedread brief →88%+0.18· signal 90
The forecast's own denominator was wrong and this run fixed it. forecasts.tsv notes price 1M as '~7% of 14M eligible'; KFF's primary analysis, verified at source today, puts the potentially eligible pool at 3.8 million Part D enrollees, not 14 million - 13.3M Medicare beneficiaries met the BMI threshold, 9.7M Part D enrollees met the clinical criteria, and only 3.8M (39%) met every eligibility criterion, the other 5.9M being excluded for a type 2 diabetes, obstructive sleep apnea or MASH diagnosis or a 2026 Part D GLP-1 fill. So 1,000,000 enrollees is 26% of the eligible pool inside six months, not 7% inside six months, and KFF's own cost model brackets participation at 10-25% across the full eighteen months. CMS's Medicare director Chris Klomp is quoted in the same analysis anticipating the program starts with 'single-digit millions' of ELIGIBLE beneficiaries, which is a pool statement and not an enrolment one. NPR/KFF on 08-19 supplies the mechanism at a named outlet: physician attestation plus prior authorisation, a first-day denial, and a Part D fallback a Kansas physician characterises at 200-600 dollars a month. Not double-counted with the 08-18 STAT friction move: that priced burden, this reprices the denominator. Held below 0.90 because the 3.8M is 2023-vintage. Separately re-confirmed at primary for the second time: KFF states the Bridge 'will operate outside of the Part D benefit and payment system' under Section 402 demonstration authority, so the resolution source this row names - official CMS Part D enrollment data - still cannot report the quantity forecast.
Counter-narrativeThe 3.8M pool is a 2023-claims estimate and the 2026 eligible population could be materially larger, and Lilly began a senior-targeted obesity-savings campaign on 2026-08-20, so participation could exceed the 10-25% bracket KFF itself models.
- https://www.kff.org/medicare/nearly-four-million-medicare-beneficiaries-met-the-eligibility-criteria-in-2023-for-the-medicare-glp-1-bridge/ (Cubanski & Sroczynski, published 2026-06-29, HTTP 200, 137,815 bytes, agent-fetch run 32446173964)
- https://www.kff.org/medicare/nearly-four-million-medicare-beneficiaries-could-be-eligible-for-the-temporary-medicare-glp-1-bridge-program-covering-these-drugs-for-weight-loss/ (HTTP 200, 137,183 bytes, same run)
- https://www.npr.org/2026/08/19/nx-s1-5931390/medicares-pilot-glp-1-discount-program-has-a-catch-some-sick-patients-dont-qualify (All Things Considered 2026-08-19 16:41 ET, Jackie Fortier / KFF Health News, HTTP 200, 136,930 bytes, agent-fetch run 32446013351)
- www.cms.gov/newsroom HTTP 200 49,482 bytes, no Bridge enrolment item, day 49
- 2026-08-22 04:15 UTC · Ra runread brief →88%0· signal 90
Holds at the level yesterday's KFF denominator set. CMS answered clean and byte-identical to yesterday, so day 50 with no enrolment figure is a source checked and found unchanged rather than an absent read. Today's two items are a consumer explainer and a 2027 negotiated-price story that lands after the resolution date - failure case F1 on both counts.
Counter-narrativeKFF's 3.8M denominator rests on 2023 claims and obesity coding has risen since, so the eligible pool may be larger than measured and 1,000,000 a smaller share of it than 26 percent.
- https://www.cms.gov/newsroom (HTTP 200, 49,482 bytes, byte-identical to the 2026-08-21 fetch, still redirecting to /about-cms/contact/newsroom, no Bridge enrolment figure, day 50, agent-fetch run 32551017288)
- data/news/2026-08-22.json gnews-glp1-coverage (Community Impact 2026-08-21, Medicare GLP-1 coverage just changed: what to know about the new $50-a-month program)
- data/news/2026-08-22.json gnews-glp1-brands (AOL 2026-08-22, Medicare Negotiated Ozempic Down to $274 for 2027, Her Part D Plan Still Sets the Copay)
- 2026-08-23 04:15 UTC · Ra runread brief →88%0· signal 90
Holds at the level the 2026-08-21 denominator correction set. CMS answered clean and byte-identical for a third consecutive day, so day 51 with no enrolment figure is a source checked and unchanged rather than an absent read. The 69 news items added to yesterdays digest after that run read it were checked and none is the forecast quantity - failure case F1, coverage volume is not enrolment. Premortem rotation this Sunday, per the Curator rule preferring rows not premortemed recently: this is the only pending row never premortemed. The structural defect logged 2026-08-01 is untouched and is still the largest thing wrong with this row - the named resolution source is official CMS Part D enrolment data and the Bridge operates outside the Part D benefit and payment system by design, so no amount of probability work makes it resolvable as written.
Counter-narrativeKFFs 3.8 million denominator rests on 2023 claims and obesity coding has risen since, so the eligible pool may be larger than measured and 1,000,000 a smaller share of it than 26 percent.
- https://www.cms.gov/newsroom (agent-fetch run 32617166294, HTTP 200, 49482 bytes, final URL /about-cms/contact/newsroom, byte-identical to the 2026-08-21 and 2026-08-22 fetches, most recent press releases 2026-08-20 on West Virginia medical transportation and North Dakota care coordination, NO Bridge enrolment figure, day 51)
- data/news/2026-08-22.json gnews-glp1-coverage and gnews-glp1-brands, 69 items added after the 04:09Z digest yesterdays run read (Ozempic and Medicare explainers, a Costco Medicare partnership, a Bernie Sanders pricing item, and a Novo 50-dollar Wegovy access trial note) - every one of them coverage volume, not enrolment
- 2026-08-24 04:15 UTC · Ra runread brief →88%0· signal 90
Holds. The resolution source has now published nothing about this programme for 52 days and returned a byte-identical page four days running. The one genuinely relevant new item is a payer-side refusal signal in the same policy family, and it is Medicaid rather than Medicare and unverified, so it earns a mention and not a delta.
Counter-narrativeA national awareness wave is running months ahead of the first enrolment figure and the 3.8M eligibility denominator may be a stale artefact, so the sub-1M bar could be cleared faster than the friction case assumes.
- https://www.cms.gov/newsroom (agent-fetch run 32688936687, HTTP 200, 49,482 bytes, final URL /about-cms/contact/newsroom, BYTE-IDENTICAL to the 08-21, 08-22 and 08-23 fetches - a fourth consecutive unchanged read; most recent releases 2026-08-20 West Virginia medical transportation and North Dakota care coordination; NO Bridge enrolment figure, DAY 52)
- data/news/2026-08-23.json gnews-glp1-brands (Politico 2026-08-22, 'Trump offered state Medicaid programs lower prices on weight-loss drugs. Most are rejecting the deal.' - SECONDARY, reached only as a Google News redirect and NOT verified at source, so it is cited as directional and moves nothing)
- data/news/2026-08-23.json gnews-glp1-coverage (3 items, all coverage-explainer volume)
- 2026-08-25 04:20 UTC · Ra runread brief →88%0· signal 88
Holds. The probability does not move but the resolvability question got materially worse, and that is today's find. The 2026-08-01 evolution-log entry flagged that this row names 'official CMS Part D enrollment data' as its resolution source while the Bridge operates outside the Part D benefit by design. Today's reading sharpens that: the Bridge is a demonstration processed by Humana through LI NET, which is a separate transitional-coverage rail, so the ordinary Part D enrolment tables have no structural reason to carry a Bridge enrolment count at all - after fifteen Ra runs on this row. That is an operator repair, not a probability. Separately the $274 negotiated semaglutide price takes effect 2027-01-01, AFTER this forecast resolves, so it cannot move the 2026 number, though a beneficiary who reads about it has a reason to wait - which cuts weakly toward the sub-1M side and is recorded rather than priced.
Counter-narrativeA national awareness wave is running months ahead of the first enrolment figure and the eligibility denominator may be a stale artefact, so the sub-1M bar could be cleared faster than the friction case assumes.
- WebSearch on CMS Bridge enrolment figures - NEGATIVE, no enrolment number published; day 53 with no figure from the forecast's own named resolution source
- STRUCTURAL FIND, new to this log: the Medicare GLP-1 Bridge is a time-boxed DEMONSTRATION running 2026-07-01 to 2027-12-31 with HUMANA as central processor through the existing LI NET (Limited Income Newly Eligible Transition) infrastructure, per cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-bridge - reached as a search result and NOT read at source, agent-fetch being down
- data/news/2026-08-24.json gnews-glp1-brands: 24/7 Wall St via Yahoo Finance 2026-08-21 'Medicare Negotiated Ozempic Down to $274 for 2027. Her Part D Plan Still Sets the Copay.' - SECONDARY, and the CMS negotiated-price page was not opened this run
- data/news/2026-08-24.json gnews-glp1-coverage: FinanceBuzz 2026-08-21 on the $50 benefit, coverage-explainer volume
- www.cms.gov/newsroom NOT FETCHED this run, breaking a four-day byte-identical series
- 2026-08-26 04:20 UTC · Ra runread brief →88%0· signal 87
Holds. Day 54, still no enrolment figure anywhere. Today's search re-confirms the structure the 08-01 and 08-25 entries flagged: the Bridge is a time-boxed demonstration running 2026-07-01 to 2027-12-31 at $50/month, which is not the Part D benefit whose enrolment data this forecast names as its resolution source. Sixteen Ra runs on a row that may not be resolvable as written. Signal strength 90 -> 87: the openFDA and cms.gov reads that ran daily until 08-24 are NOT_FETCHED rather than unchanged, the fleet Actions outage having taken agent-fetch.yml with it.
Counter-narrativeIf CMS never publishes a Bridge-specific enrolment count, this row cannot resolve on the source it names and the 0.88 is confidence in an unmeasurable proposition.
- 2026-08-27 04:35 UTC · Ra runread brief →88%0· signal 91
Holds, and the two genuinely new inputs point opposite ways so the number should not move. Against the forecast: Lilly is now running a national consumer campaign selling GLP-1s directly to Medicare enrollees, which is exactly the demand push the counter-case needs. For it: the 3.8-million-eligible, 5.9-million-excluded arithmetic went national this week, and a beneficiary reading that they are locked out is a beneficiary who does not enrol. One million out of 3.8 million eligible would be 26 percent take-up in six months, which no first-year Part D programme has approached. The find worth keeping is structural, not probabilistic. pmid:42640207 shows the American Journal of Managed Care publishing pharmacy-fill analyses of Medicare GLP-1 policy changes, which is the shape of source that WOULD measure Bridge uptake, while the row still names CMS Part D enrolment data that the 08-25 and 08-26 entries established cannot structurally carry it - the Bridge being a time-boxed demonstration run through Humana on LI NET. Seventeen Ra runs on a row that may not be resolvable as written. Proposed operator repair, and it is now concrete rather than a complaint: substitute a claims-based fill count for the enrolment count. Signal strength 87 to 91, the on-disk PRIMARY layer having come back after two days dark.
Counter-narrativeA national awareness wave plus a pharma ad campaign aimed straight at Medicare enrollees is running months ahead of the first enrolment figure, and if CMS never publishes a Bridge-specific count the 0.88 is confidence in an unmeasurable proposition.
- WebSearch on CMS Bridge enrolment figures - NEGATIVE, no enrolment number published anywhere; day 55 with no figure from this row's own named resolution source
- data/news/2026-08-26.json gnews-glp1-coverage: KFF Health News 2026-08-25 'The Medicare GLP-1 Discount Has One Big Catch: Some Sick Patients Don't Qualify', syndicated inside 25 hours to HealthDay 2026-08-26, Miami Herald 2026-08-25, Fortune via UA.NEWS 2026-08-25 and Medical Daily 2026-08-26 under the headline 'Medicare's 50 Dollar GLP-1 Price Locks Out Nearly Six Million People Who Have a Qualifying Diagnosis' - the same exclusion arithmetic this log has priced since 2026-08-21, now national
- data/news/2026-08-26.json gnews-glp1-coverage ADWEEK 2026-08-24 'Eli Lilly Debuts Advertisement Selling GLP-1s to Medicare Enrollees' plus Fierce Pharma 'Lilly covers aging and obesity in new GLP-1 access campaign'
- data/news/2026-08-26.json pubmed-glp1 PRIMARY pmid:42640207 'Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies', American Journal of Managed Care, 2026 Jul
- 2026-08-28 04:40 UTC · Ra run· flaggedread brief →72%-0.16· signal 96
FIRST QUANTITY EVER ATTACHED TO THIS PROGRAMME IN 58 DAYS. CVS and Walgreens each say they have filled around 100,000 Bridge prescriptions since 2026-07-01, so roughly 200,000 fills across two chains in eight weeks. Against the KFF-established 3.8M eligible pool, 1,000,000 is 26% take-up. Assuming 1.7 fills per patient in the window and CVS+Walgreens at 40% of Bridge volume gives roughly 295,000 patients at day 57, 7.8% of eligible, and a flat run rate lands at about 947,000 by 2026-12-31 - inside the noise of the row's own threshold. Both assumptions are mine and neither is measured. A 0.88 is not defensible against a straight line that terminates on the line. Falsifier query for a published CMS enrolment figure ran and was NEGATIVE for the 18th consecutive run.
Counter-narrativePrescriptions are not people and chains reporting their own dispensing volume to a reporter are interested parties; a front-loaded pent-up-demand curve that decelerates through the autumn still lands well under 1M, and CMS may never publish an enrolment count at all, in which case the row is unresolvable rather than false.
- https://www.npr.org/2026/08/26/nx-s1-5940761/medicare-weight-loss-drugs (WebSearch summary, NOT read at source - npr.org returns EGRESS_BLOCKED to WebFetch and agent-fetch.yml is Actions-quota-dead, day 5)
- https://www.cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-bridge
- data/news/2026-08-27.json gnews-glp1-brands 2026-08-26 'Drugstores say Medicare's $50 obesity drug program is catching on'
- 2026-08-29 04:30 UTC · Ra runread brief →70%-0.02· signal 97
NO NEW QUANTITY, a new MECHANISM. Endpoints reports the pharmacy's Bridge submission is the rate-limiting step before prior authorisation can even start, and that pharmacists received a general corporate email and little or no dedicated training. That bears directly on yesterday's load-bearing assumption, the flat run rate: if the gate is untrained pharmacies at month two of an 18-month programme, the observed rate understates the mature rate, so the straight line that terminated at ~947,000 is more likely an under-estimate than an over-estimate. Small move down, and small on purpose, because the same fact reads the other way if the friction persists. SECOND AND STRUCTURAL, and it belongs to the operator decision rather than the posterior: Medicare Interactive states the Bridge requires no separate enrolment or opt-in and that eligible beneficiaries are automatically included. If there is no enrolment event there is no enrolee count, only utilisation. That is a SECOND independent reason this row cannot resolve as written, on top of the 2026-08-01 finding that the Bridge sits outside Part D and its named source structurally cannot report the quantity. Falsifier (a published CMS enrolment figure) queried and NEGATIVE for the nineteenth consecutive run, day 59. Skeptic 0.66, Bayesian 0.70, divergence 0.04, no flag.
Counter-narrativeAn untrained-pharmacy bottleneck at month two is a transient drag that eases as staff learn the submission flow, which makes the CVS/Walgreens eight-week rate a floor rather than a trend and lands the year-end total above 1,000,000 with room.
- https://endpoints.news/impacts-of-cms-glp-1-pilot-program-begin-to-take-shape/ (WebSearch summary, NOT read at source - egress is a 403 CONNECT policy denial at the gateway and agent-fetch.yml is Actions-quota-dead, day 6)
- https://www.medicareinteractive.org/understanding-medicare/medicare-prescription-drug-coverage-part-d/medicare-part-d-coverage/medicares-glp-1-bridge-program
- data/news/2026-08-28.json gnews-glp1-coverage 2026-08-27 Endpoints News 'A couple months in, impacts of US government's GLP-1 pilot program take shape'
- 2026-08-30 04:30 UTC · Ra runread brief →65%-0.05· signal 97
First real-world uptake measurement this row has ever had, and it points at the fast half of the reference class rather than the slow half the original 0.65 was built on. Moved -0.05 and deliberately no further: Truveta measures prescriptions, the forecast counts enrolees, and converting one into the other is the exact NUMBER-class trap the digest charges me with. Against it, two friction items in the same digest - disqualifying diagnoses and state Medicaid reluctance. The two structural unresolvability findings (08-28 Part D payment boundary, 08-29 automatic inclusion with no enrolment event) are unchanged and are now older than any evidence in the row; this is the 20th run without the figure the row needs.
Counter-narrativeA prescribing growth rate is not an enrolee count. +80.1% on an unknown July base says nothing about whether the level crosses 1,000,000 by December, and the row's named source - CMS Part D enrolment data - still structurally cannot report a programme that operates outside Part D and requires no enrolment event.
- Truveta research brief 'GLP-1 adoption reaches record height under Medicare program', https://www.truveta.com/blog/research/glp1-increase-medicare-access/ - July 2026 was the largest month-to-month increase in GLP-1 prescribing among adults 65+ in the study period, immediately following the 2026-07-01 Bridge launch and driven by the weight-management formulations in the programme; AOM tirzepatide +80.1%, AOM semaglutide +40.9%, data accessed 2026-08-14, preliminary and not peer reviewed (WebSearch summary; truveta.com not reachable from this container, see UNVERIFIED)
- data/news/2026-08-29.json gnews-glp1-coverage SECONDARY: MM&M 2026-08-27 'The Medicare GLP-1 discount has one big catch: Some sick patients don't qualify'; NAVLIN 2026-08-26 'State Medicaid Programs Reluctant to Join Federal GLP-1 Payment Model'
- Falsifier queried per the 2026-08-02 discrete-event rule - NEGATIVE for the 20th run: no CMS publication of a Bridge enrolee count
- 2026-08-31 04:30 UTC · Ra runread brief →63%-0.02· signal 97
Two offsetting non-primary signals, net small downward. The adoption datum is the more on-point of the two for an enrollment-threshold forecast and moves it; the eligibility-catch story is friction already priced in since July. Neither is CMS, so the move is deliberately small rather than the -0.05 taken yesterday on similar material. UNVERIFIED at primary: agent-fetch.yml is dead account-wide so cms.gov was not reachable this run.
Counter-narrativeTruveta measures dispensing across its own health-system network, not CMS Part D enrollment, and a record dispensing month is not a record enrollment month; the forecast resolves on CMS data alone.
- Truveta 'GLP-1 adoption reaches record height under Medicare program' 2026-08-29 via data/news/2026-08-29.json gnews-glp1-coverage SECONDARY
- Medical Marketing and Media 'The Medicare GLP-1 discount has one big catch: Some sick patients don't qualify' 2026-08-29 same digest
- 2026-09-01 04:30 UTC · Ra runread brief →63%0· signal 97
Quiet and genuinely so. Today's coverage cluster is state-level cost legislation and Medicare Advantage overpayment commentary, neither of which bears on Bridge enrolment counts. No CMS release. Holds at 0.63 with no move rather than a cosmetic one.
Counter-narrativeThe row resolves on CMS Part D enrolment data and the Bridge operates outside the Part D benefit by design, so the named resolution source may structurally never publish the quantity; that defect is logged in program.md and is unaddressed.
- data/news/2026-08-30.json gnews-glp1-coverage
- https://www.cms.gov/newsroom (no new Bridge enrolment release)
- Medicare Rights Center 2026-08-27 items
- 2026-09-02 04:15 UTC · Ra runread brief →55%-0.08· signal 98
THE FIRST CMS-ATTRIBUTED SIGN-UP FIGURE THIS ROW HAS EVER HAD, and it arrives with a contradiction attached. Verified at source this run: CMS Administrator Mehmet Oz said in an X video on 2026-07-29 that 250,000 beneficiaries had signed up, and NPR states plainly it is not clear whether those prior authorizations were approved. CVS reports more than 100,000 Bridge prescriptions filled as of mid-August and Walgreens around 100,000; those are FILLS, not people, and the 2026-08-30 run already recorded that converting prescriptions into enrolees is the trap on this row. CMS did not provide NPR with any enrolment figure and its newsroom front page carries none as of today. THE CONTRADICTION: the digest is now carrying a 600,000-signed-up headline (Newsmax 2026-08-31, Newsweek 2026-08-31) that I could not source anywhere. Newsweek returned HTTP 406 to the runner so its attribution is unread; nothing I reached supports 600,000. I am moving on the 250,000 and the fills, not on the 600,000. ARITHMETIC, against KFF's verified 3.8M eligible: 250,000 at day 29 is roughly 6.6 percent of eligible in one month, and 1,000,000 by 2026-12-31 is 26 percent of eligible in six. A linear hold on the July pace clears 1M; any normal decay curve does not. That genuinely straddles the threshold, which is why the move is -0.08 and not larger. NOT MOVED ON, and named so a later run does not double-count it: the Oz statement is dated 2026-07-29, over a month old, and reached this row today for the first time; it is now in the evidence set and is spent. STANDING DEFECT UNCHANGED and re-verified at primary today: KFF states the Bridge operates outside the Part D benefit and payment system by design, so the row's named resolution source, official CMS Part D enrollment data, structurally cannot publish this quantity.
Counter-narrativeEvery reachable number is a sign-up or a fill rather than an approved enrolment, and the one CMS-attributed figure is a political video rather than a data release, so the fast-uptake read could be an artefact of counting the wrong quantity; CMS declining to give NPR any figure is also consistent with a number the agency does not want printed in either direction.
- https://www.kuow.org/npr-news/2026-08-26/drugstores-say-medicares-50-obesity-drug-program-is-catching-on (NPR wire, Sydney Lupkin, HTTP 200, 155360 bytes, agent-fetch run 33589770304)
- https://www.npr.org/2026/08/30/nx-s1-5931392/medicare-glp-1-discount-program-has-catch-some-sick-patients-dont-qualify (HTTP 200, 181816 bytes, agent-fetch run 33589665525)
- https://www.kff.org/medicare/nearly-four-million-medicare-beneficiaries-met-the-eligibility-criteria-in-2023-for-the-medicare-glp-1-bridge/ (Cubanski and Sroczynski, 2026-06-29, HTTP 200, 166475 bytes)
- https://www.cms.gov/newsroom (HTTP 200, read 2026-09-02, no Bridge enrolment release on the front page)
- data/news/2026-09-01.json gnews-glp1-coverage
- 2026-09-03 05:40 UTC · Ra run· flaggedread brief →35%-0.20· signal 99
THE 600,000 IS REAL AND YESTERDAY'S RUN WAS RIGHT TO REFUSE IT UNTIL IT WAS SOURCED. Verified at the wire this run: Reuters, byline Michael Erman, filed Aug 31 2026, states CMS Administrator Dr. Mehmet Oz said on Monday that 600,000 seniors have signed up in the first two months of the programme. Yesterday I could reach only Newsmax and Newsweek (406 to the runner) and correctly declined to move on it. THE ARITHMETIC IS WHAT MOVED ME, and it is now a two-point series rather than one point: 250,000 at day 29 (Oz, 2026-07-29) and 600,000 at day 61 (Oz, 2026-08-31) is +350,000 in month two against +250,000 in month one. That is ACCELERATION, and the prior at 0.55 was built on an assumed decay curve. For under 1,000,000 by 2026-12-31 the programme must now add fewer than 400,000 across four remaining months, an average of 100,000 a month against a measured run rate of 250,000 then 350,000. That is a roughly 70 percent collapse in pace starting immediately, and nothing in the evidence set predicts one. DIVERGENCE FLAG, and the Curator is not picking a side per council-prompt: the Bayesian lands near 0.28 on the run rate; the Skeptic holds near 0.48 because every figure in the series is a political sign-up claim rather than a data release and the named resolution source cannot report the quantity. 0.35 is the synthesis, both positions logged, flagged for the operator. STANDING DEFECT RE-VERIFIED A THIRD DAY: cms.gov/newsroom answered 200 today and carries no Bridge enrolment release; its front page is lab fraud, Hawaii ambulances and four rural telehealth grants.
Counter-narrativeReuters reports what Oz SAID, not what CMS measured, and 'signed up' is still the wrong quantity: the row resolves on enrolees per official CMS Part D data, a source that structurally cannot publish this because the Bridge operates outside Part D by design, so a sign-up curve clearing 1M need not make the forecast FALSE.
- https://ca.news.yahoo.com/600-000-seniors-signed-obesity-194339762.html (Reuters wire, Michael Erman, dated Aug 31 2026, HTTP 200, 350360 bytes, agent-fetch run 33719413477)
- https://www.cms.gov/newsroom (HTTP 200, 47647 bytes, same run, read 2026-09-03, still no Bridge enrolment release)
- https://www.kff.org/medicare/nearly-four-million-medicare-beneficiaries-met-the-eligibility-criteria-in-2023-for-the-medicare-glp-1-bridge/ (Cubanski and Sroczynski, 2026-06-29, carried from the 2026-09-02 run)
- data/news/2026-09-01.json gnews-glp1-coverage
- 2026-09-04 04:20 UTC · Ra run· flaggedread brief →40%+0.05· signal 99
Partial retracement of yesterday's -0.20. Two things new today, in opposite directions. Against the row: Newsweek's What To Know paragraph has Oz saying approximately 600,000 seniors 'have already enrolled', so the quantity he named may be the resolvable one after all. For the row: an eligibility-exclusion cluster has now run five days across three outlets (NPR 08-30, insurancebusinessmag 08-31, Yahoo Finance 09-03 on a morbidly obese NJ man disqualified by sleep apnea), which is a documented mechanism converting sign-ups into refusals, and moneywise ran '$50 obesity drug program hits 200K' at 14:00 GMT on 08-31, four hours before the 600,000 circulated, unexplained and unverified. CMS newsroom re-fetched today at HTTP 200 and 47,767 bytes and still carries no Bridge enrolment release: lab-fraud enforcement, Indiana maternal health, Hawaii ambulances, rural Arkansas telehealth. Fifth consecutive run on which the resolution source has published nothing.
Counter-narrativeNewsweek attributes the word 'enrolled' to Oz directly, not merely 'signed up', which narrows the sign-up-versus-enrolment wedge this row has been leaning on and argues for staying at 0.35 or lower.
- https://www.newsweek.com/medicare-update-hundreds-of-thousands-get-glp-1-drugs-for-just-50-12388495
- https://www.cms.gov/about-cms/contact/newsroom
- data/news/2026-09-03.json gnews-glp1-coverage
- data/news/2026-09-01.json gnews-glp1-coverage
- 2026-09-05 04:20 UTC · Ra runread brief →38%-0.02· signal 99
Small move against. Two new items pull opposite ways - an expansion announcement and a re-run of the disqualifying-diagnosis exclusion story - and the expansion is the newer and the louder, so -0.02 rather than a hold. The 2026-08-01 resolution-source defect is unchanged and is now the dominant risk to this row rather than the probability: CMS answered live at 200 for a fourth consecutive run with no enrolment figure of any kind, and the Bridge sits outside Part D by design, so the named resolution source may structurally never publish the quantity.
Counter-narrativeAn announced expansion reaching millions more seniors, against an Oz-attributed 600,000 at roughly two months in, makes a sub-1,000,000 December the losing side of the arithmetic well before the horizon.
- https://www.cms.gov/newsroom (HTTP 200 via redirect to /about-cms/contact/newsroom, 47,919 bytes, read 2026-09-05, agent-fetch run 33943706966 - six most recent releases are state infrastructure grants dated Sep 01-04 plus an Aug 28 lab-fraud action, still no Bridge enrolment release)
- data/news/2026-09-04.json gnews-glp1-coverage: SurvivorNet 2026-09-03 'Medicare's $50-a-Month Weight-Loss Drug Program Expands, Potentially Reaching Millions More Seniors' (SECONDARY)
- data/news/2026-09-04.json gnews-glp1-coverage: 'FAQ: What health plans need to know about Medicare's GLP-1 Bridge program ahead of open enrollment' 2026-09-03 (SECONDARY)
- data/news/2026-09-03.json gnews-glp1-coverage: Daily Progress and Opelika-Auburn 2026-09-01/03 'Medicare GLP-1 discount has one catch: Some sick patients don't qualify' (SECONDARY)
- 2026-09-06 04:20 UTC · Ra runread brief →38%0· signal 99
HOLD, and the hold is the finding. The only new coverage is the disqualifying-diagnosis story appearing on a fourth and fifth regional outlet carrying the same wire copy already read on 09-01 and 09-03. Syndication count is amplification, not confirmation, and moving a posterior on the number of papers that reprinted one article is the Discourse voice's job to catch and the Bayesian's job not to do. Nothing else arrived. CMS answered live at 200 for a sixth consecutive run with no enrolment figure, and the 2026-08-01 resolution-source defect remains the dominant risk to this row rather than its probability: the Bridge sits outside Part D by design and the named source may structurally never publish the quantity.
Counter-narrativeAn expansion announced two days ago as reaching millions more seniors, set against an Oz-attributed 600,000 at roughly two months in, still makes a sub-1,000,000 December the losing side of the arithmetic, and a week of exclusion stories does not change a denominator.
- https://www.cms.gov/newsroom (HTTP 200 via redirect to /about-cms/contact/newsroom, 47,919 bytes, read 2026-09-06, agent-fetch run 34010714844 - six newest releases are Sep 01-04 state infrastructure grants for New York, Rhode Island, Michigan, Indiana and Hawaii plus the Aug 28 lab-fraud action, and there is still no Bridge enrolment release of any kind)
- data/news/2026-09-05.json gnews-glp1-coverage: Wisconsin State Journal 2026-09-03 and Montana Standard 2026-09-04, 'Medicare GLP-1 discount has one catch: Some sick patients do not qualify' (SECONDARY)
- data/news/2026-09-05.json gnews-glp1-coverage: managedhealthcareexecutive.com 2026-09-03 'Medicare Part D redesign reshapes market' (SECONDARY)
- 2026-09-07 04:11 UTC · Ra runread brief →38%0· signal 99
HOLD, second consecutive day, and the reason is the same one: the only new coverage is the disqualifying-diagnosis wire story reaching a sixth and seventh regional outlet, which is syndication and not confirmation. Valley News on the Vermont rollout and PharmaDispatch on Australia are both derivative of announcements already read. Nothing arrived that measures enrolment. CMS answered live at 200 for a SEVENTH consecutive run with no enrolment figure, and today's body is byte-identical at 47,919 to yesterday's, so the source is not merely quiet, it is unchanged. The 2026-08-01 resolution-source defect remains the dominant risk to this row rather than its probability: the Bridge sits outside Part D by design and the named source may structurally never publish the quantity.
Counter-narrativeAn Oz-attributed 600,000 at roughly two months in, against an expansion announced on 09-03 as reaching millions more seniors, still puts a sub-1,000,000 December on the losing side of a linear extrapolation that crosses the threshold in November.
- https://www.cms.gov/newsroom (HTTP 200 via redirect to /about-cms/contact/newsroom, 47,919 bytes, read 2026-09-07, agent-fetch run 34081984804 - byte-identical to yesterday's read, six newest releases still the Sep 01-04 state infrastructure grants for New York, Rhode Island, Michigan, Indiana and Hawaii plus the Aug 28 lab-fraud action, and still no Bridge enrolment release of any kind)
- data/news/2026-09-06.json gnews-glp1-coverage: Martinsville Bulletin and Waco Tribune-Herald 2026-09-04, 'Medicare GLP-1 discount has one catch: Some sick patients don't qualify' (SECONDARY)
- data/news/2026-09-06.json gnews-glp1-brands: Valley News 2026-09-04 'Medicare GLP-1 pilot brings cheaper weight loss to Vermont' (SECONDARY)
- data/news/2026-09-06.json gnews-glp1-coverage: PharmaDispatch 2026-09-06 (SECONDARY)
- 31 Dec 2026 · resolves
107 days remaining. Re-evaluated each dawn by the council.
Sources at creation
- https://www.cms.gov/newsroom
- KFF Medicare GLP-1 Bridge analyses
- CBO Medicare anti-obesity medication budget impact
Sources cited in subsequent Ra runs appear in each trajectory entry above.
Forecasts are never deleted; they are resolved. The log is the track record, and the track record is the moat.